JP5758174B2 - Antioxidants and antioxidant cosmetics - Google Patents
Antioxidants and antioxidant cosmetics Download PDFInfo
- Publication number
- JP5758174B2 JP5758174B2 JP2011079710A JP2011079710A JP5758174B2 JP 5758174 B2 JP5758174 B2 JP 5758174B2 JP 2011079710 A JP2011079710 A JP 2011079710A JP 2011079710 A JP2011079710 A JP 2011079710A JP 5758174 B2 JP5758174 B2 JP 5758174B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- medium
- yeast
- gold
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000003078 antioxidant effect Effects 0.000 title claims description 38
- 239000003963 antioxidant agent Substances 0.000 title claims description 27
- 239000002537 cosmetic Substances 0.000 title claims description 23
- 239000000284 extract Substances 0.000 claims description 180
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 59
- 229910052709 silver Inorganic materials 0.000 claims description 59
- 239000004332 silver Substances 0.000 claims description 59
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 58
- 229910052737 gold Inorganic materials 0.000 claims description 58
- 239000010931 gold Substances 0.000 claims description 58
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 56
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 42
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 20
- 229910052757 nitrogen Inorganic materials 0.000 claims description 14
- 238000001704 evaporation Methods 0.000 claims description 11
- 230000008020 evaporation Effects 0.000 claims description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 239000011574 phosphorus Substances 0.000 claims description 7
- 229910052698 phosphorus Inorganic materials 0.000 claims description 7
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 claims description 6
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 5
- 229940044197 ammonium sulfate Drugs 0.000 claims description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 5
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 4
- 239000004202 carbamide Substances 0.000 claims description 4
- 235000021317 phosphate Nutrition 0.000 claims description 4
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims description 4
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 claims description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 3
- 229940024606 amino acid Drugs 0.000 claims description 3
- 235000001014 amino acid Nutrition 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 235000018417 cysteine Nutrition 0.000 claims description 3
- 229960002433 cysteine Drugs 0.000 claims description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 2
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 claims description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 2
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- 235000004279 alanine Nutrition 0.000 claims description 2
- 229960003767 alanine Drugs 0.000 claims description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- 235000019270 ammonium chloride Nutrition 0.000 claims description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 235000009697 arginine Nutrition 0.000 claims description 2
- 229960003121 arginine Drugs 0.000 claims description 2
- 235000009582 asparagine Nutrition 0.000 claims description 2
- 229960001230 asparagine Drugs 0.000 claims description 2
- 235000003704 aspartic acid Nutrition 0.000 claims description 2
- 229960005261 aspartic acid Drugs 0.000 claims description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 2
- 235000019797 dipotassium phosphate Nutrition 0.000 claims description 2
- 150000002016 disaccharides Chemical class 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 2
- 235000004554 glutamine Nutrition 0.000 claims description 2
- 235000014304 histidine Nutrition 0.000 claims description 2
- 229960002885 histidine Drugs 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- 235000014705 isoleucine Nutrition 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 235000005772 leucine Nutrition 0.000 claims description 2
- 229960003136 leucine Drugs 0.000 claims description 2
- 235000018977 lysine Nutrition 0.000 claims description 2
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 claims description 2
- 229930182817 methionine Natural products 0.000 claims description 2
- 235000006109 methionine Nutrition 0.000 claims description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- 235000008729 phenylalanine Nutrition 0.000 claims description 2
- 229960005190 phenylalanine Drugs 0.000 claims description 2
- 239000004323 potassium nitrate Substances 0.000 claims description 2
- 235000010333 potassium nitrate Nutrition 0.000 claims description 2
- 235000013930 proline Nutrition 0.000 claims description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims description 2
- 235000004400 serine Nutrition 0.000 claims description 2
- 229960001153 serine Drugs 0.000 claims description 2
- 235000010344 sodium nitrate Nutrition 0.000 claims description 2
- 239000004317 sodium nitrate Substances 0.000 claims description 2
- 235000008521 threonine Nutrition 0.000 claims description 2
- 229960002898 threonine Drugs 0.000 claims description 2
- 150000004043 trisaccharides Chemical class 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 235000002374 tyrosine Nutrition 0.000 claims description 2
- 235000014393 valine Nutrition 0.000 claims description 2
- 229960004295 valine Drugs 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- 229930006000 Sucrose Natural products 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 229960001040 ammonium chloride Drugs 0.000 claims 1
- 150000003863 ammonium salts Chemical class 0.000 claims 1
- 229960002989 glutamic acid Drugs 0.000 claims 1
- 229960002743 glutamine Drugs 0.000 claims 1
- 229960003646 lysine Drugs 0.000 claims 1
- 229960004452 methionine Drugs 0.000 claims 1
- 150000002772 monosaccharides Chemical class 0.000 claims 1
- 150000002823 nitrates Chemical class 0.000 claims 1
- 235000011007 phosphoric acid Nutrition 0.000 claims 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 229960004799 tryptophan Drugs 0.000 claims 1
- 239000002609 medium Substances 0.000 description 59
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 38
- -1 amine compounds Chemical class 0.000 description 35
- 210000005253 yeast cell Anatomy 0.000 description 31
- 210000004027 cell Anatomy 0.000 description 30
- 235000019645 odor Nutrition 0.000 description 30
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 26
- 239000000203 mixture Substances 0.000 description 24
- 239000001963 growth medium Substances 0.000 description 23
- 235000006708 antioxidants Nutrition 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 18
- 235000019441 ethanol Nutrition 0.000 description 18
- 210000003491 skin Anatomy 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 17
- 238000012258 culturing Methods 0.000 description 17
- 239000006210 lotion Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- 239000000194 fatty acid Substances 0.000 description 13
- 239000000419 plant extract Substances 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 229940058015 1,3-butylene glycol Drugs 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- 235000019437 butane-1,3-diol Nutrition 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 244000005700 microbiome Species 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 240000007594 Oryza sativa Species 0.000 description 8
- 235000007164 Oryza sativa Nutrition 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 235000009566 rice Nutrition 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 229930014626 natural product Natural products 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 230000002421 anti-septic effect Effects 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 239000013028 medium composition Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 6
- 239000007218 ym medium Substances 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 241001570521 Lonicera periclymenum Species 0.000 description 5
- 102000019197 Superoxide Dismutase Human genes 0.000 description 5
- 108010012715 Superoxide dismutase Proteins 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 4
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 206010051246 Photodermatosis Diseases 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 229940023476 agar Drugs 0.000 description 4
- 235000010419 agar Nutrition 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 210000001339 epidermal cell Anatomy 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 230000008845 photoaging Effects 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 241001474374 Blennius Species 0.000 description 3
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 3
- 241000195628 Chlorophyta Species 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 241000199919 Phaeophyceae Species 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 241000206572 Rhodophyta Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 229940069521 aloe extract Drugs 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000001877 deodorizing effect Effects 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 3
- 229940069445 licorice extract Drugs 0.000 description 3
- 230000008099 melanin synthesis Effects 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 235000019271 petrolatum Nutrition 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 150000003464 sulfur compounds Chemical class 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 241000254173 Coleoptera Species 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 240000000731 Fagus sylvatica Species 0.000 description 2
- 235000010099 Fagus sylvatica Nutrition 0.000 description 2
- 241001071795 Gentiana Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 241000736199 Paeonia Species 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- MJEMIOXXNCZZFK-UHFFFAOYSA-N ethylone Chemical compound CCNC(C)C(=O)C1=CC=C2OCOC2=C1 MJEMIOXXNCZZFK-UHFFFAOYSA-N 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 229940099596 manganese sulfate Drugs 0.000 description 2
- 239000011702 manganese sulphate Substances 0.000 description 2
- 235000007079 manganese sulphate Nutrition 0.000 description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- JKQOBWVOAYFWKG-UHFFFAOYSA-N molybdenum trioxide Chemical compound O=[Mo](=O)=O JKQOBWVOAYFWKG-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 239000011684 sodium molybdate Substances 0.000 description 2
- 235000015393 sodium molybdate Nutrition 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 229940074410 trehalose Drugs 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- QVSVMNXRLWSNGS-UHFFFAOYSA-N (3-fluorophenyl)methanamine Chemical compound NCC1=CC=CC(F)=C1 QVSVMNXRLWSNGS-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- LNJRMYPOKFOJBQ-UHFFFAOYSA-N 1-(4-tert-butyl-4-methoxycyclohexa-1,5-dien-1-yl)ethanone Chemical compound COC1(C(C)(C)C)CC=C(C(C)=O)C=C1 LNJRMYPOKFOJBQ-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical class OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- CAKGLMPBYAPFCR-UWBMNBDUSA-N Bemisiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 CAKGLMPBYAPFCR-UWBMNBDUSA-N 0.000 description 1
- 101710130006 Beta-glucanase Proteins 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 240000005109 Cryptomeria japonica Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 102000002045 Endothelin Human genes 0.000 description 1
- 108050009340 Endothelin Proteins 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000555682 Forsythia x intermedia Species 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 108010058643 Fungal Proteins Proteins 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000013628 Lantana involucrata Nutrition 0.000 description 1
- 240000005183 Lantana involucrata Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- 241001072282 Limnanthes Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000508269 Psidium Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 244000151637 Sambucus canadensis Species 0.000 description 1
- 235000018735 Sambucus canadensis Nutrition 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241000256011 Sphingidae Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 235000009319 Terminalia catappa Nutrition 0.000 description 1
- 244000277583 Terminalia catappa Species 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 150000001545 azulenes Chemical class 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 230000037365 barrier function of the epidermis Effects 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000007123 blue elder Nutrition 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 229940073724 cholesteryl isostearate Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 239000012225 czapek media Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000010389 delta-tocopherol Nutrition 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical class [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229940012466 egg shell membrane Drugs 0.000 description 1
- 235000007124 elderberry Nutrition 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- RBHFPIHDGCGQPN-UHFFFAOYSA-N ethyl 3,8-dimethyl-5-propan-2-ylazulene-1-sulfonate Chemical compound C1=C(C(C)C)C=CC(C)=C2C(S(=O)(=O)OCC)=CC(C)=C21 RBHFPIHDGCGQPN-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- QFWPJPIVLCBXFJ-UHFFFAOYSA-N glymidine Chemical compound N1=CC(OCCOC)=CN=C1NS(=O)(=O)C1=CC=CC=C1 QFWPJPIVLCBXFJ-UHFFFAOYSA-N 0.000 description 1
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical group CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000011177 media preparation Methods 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 229940117336 parsley extract Drugs 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 229940083256 peripheral vasodilators nicotinic acid and derivative Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 235000021013 raspberries Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229940119485 safflower extract Drugs 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229950002760 sodium gualenate Drugs 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GEYJUFBPCGDENK-UHFFFAOYSA-M sodium;3,8-dimethyl-5-propan-2-ylazulene-1-sulfonate Chemical compound [Na+].CC(C)C1=CC=C(C)C2=C(S([O-])(=O)=O)C=C(C)C2=C1 GEYJUFBPCGDENK-UHFFFAOYSA-M 0.000 description 1
- PVGBHEUCHKGFQP-UHFFFAOYSA-N sodium;n-[5-amino-2-(4-aminophenyl)sulfonylphenyl]sulfonylacetamide Chemical compound [Na+].CC(=O)NS(=O)(=O)C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 PVGBHEUCHKGFQP-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
- 239000002446 δ-tocopherol Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、特定培地で培養したSaccharomyces cerevisiae 酵母の菌体抽出液からなることを特徴とする抗酸化剤、およびこれを配合した化粧料に関する。 TECHNICAL FIELD The present invention relates to an antioxidant comprising a cell extract of Saccharomyces cerevisiae yeast cultured in a specific medium, and a cosmetic containing the same.
近年、老化の原因としてフリーラジカルや活性酸素がとりあげられ、生体成分の酸化による機能低下が大きな問題となっている。なかでも紫外線に常にさらされている皮膚は、このような酸化ストレスのダメージが最も大きな器官の一つであり、紫外線により発生した種々の活性酸素が、皮脂や脂質の過酸化、蛋白変性、酵素阻害等を引き起こし、皮膚の炎症などの原因となる。また、紫外線により真皮のヒアルロン酸やコラーゲンの産生が低下すると共に、コラーゲンの変性が生じ、肌の弾力やハリが低下しシワの原因になる。さらに、表皮細胞が紫外線に照射されると各種のサイトカインを産生し、メラニン産生を増大させることが知られている。例えばエンドセリンやチオレドキシンなどのサイトカインは、紫外線照射により表皮細胞から産生され、メラノサイトに働きかけてメラニン産生を促進させ光老化によるシミの原因になっている。これら紫外線が原因となって生じるシワ・シミを防ぐ方法の一つにフリーラジカルや活性酸素を除去する抗酸化剤を配合する方法が知られている。 In recent years, free radicals and active oxygen have been taken up as causes of aging, and functional degradation due to oxidation of biological components has become a major problem. The skin that is constantly exposed to ultraviolet rays is one of the organs that are most damaged by such oxidative stress, and various active oxygen generated by ultraviolet rays is used to peroxidize sebum and lipids, protein denaturation, enzymes Causes inhibition and other causes of skin irritation. In addition, the production of hyaluronic acid and collagen in the dermis is reduced by ultraviolet rays, and collagen is denatured, and the elasticity and firmness of the skin is reduced, causing wrinkles. Furthermore, it is known that when epidermal cells are irradiated with ultraviolet rays, various cytokines are produced and melanin production is increased. For example, cytokines such as endothelin and thioredoxin are produced from epidermal cells by ultraviolet irradiation and act on melanocytes to promote melanin production and cause spots due to photoaging. As one of methods for preventing wrinkles and spots caused by ultraviolet rays, a method of blending an antioxidant that removes free radicals and active oxygen is known.
生体は活性酸素種を除去する自己防御機構としてSODなどの抗酸化機構を有しているものの、生体組織の防御能力を超えた活性酸素が生体組織の老化の原因となっている。フリーラジカルを捕捉する能力を備える抗酸化剤は、ラジカル連鎖反応を抑制・停止させることができるので、このような抗酸化剤を配合した皮膚外用剤は、光酸化ストレスによる皮膚老化、例えば、シミ、しわ、たるみなどの予防・改善効果が期待できる。このため、従来より光老化によるシワ防止を目的として用いられるフリーラジカル消去剤にはアスコルビン酸、トコフェロール、3,5−tert−ブチル−4−ヒドロキシトルエン(BHT)、スーパーオキシドジスムターゼ(SOD)等が用いられてきた。 Although the living body has an antioxidant mechanism such as SOD as a self-protecting mechanism for removing reactive oxygen species, active oxygen exceeding the defense ability of living tissue causes aging of living tissue. Antioxidants with the ability to scavenge free radicals can suppress and stop the radical chain reaction. Therefore, topical skin preparations containing such antioxidants can cause skin aging due to photooxidative stress, such as stains. Can be expected to prevent, improve wrinkles and sagging. For this reason, ascorbic acid, tocopherol, 3,5-tert-butyl-4-hydroxytoluene (BHT), superoxide dismutase (SOD) and the like have been conventionally used for the purpose of preventing wrinkles due to photoaging. Has been used.
しかし、皮膚の光老化防止又は抗酸化を目的として用いられるSODは不安定であり、製剤化が難しく、トコフェロールも効果が充分であるとは言えない。また、合成化合物であるBHT等は安全性に問題があり、配合量に制限があることから、化学合成品ではなく、安定でかつ副作用が少ないとともにより効果の高い天然原料が望まれてきた。 However, SOD used for the purpose of preventing skin photoaging or anti-oxidation is unstable, difficult to formulate, and tocopherol is not effective enough. Moreover, since BHT etc. which are synthetic compounds have a safety | security problem and there exists a restriction | limiting in compounding quantity, it is not a chemically synthesized product but the natural raw material which is stable and has few side effects, and was more effective has been desired.
抗酸化性の高い天然物質として、健康食品や化粧品にはハーブ植物が多く用いられてきた。しかし、これらの植物抽出物は色、臭いが強く、化粧料に配合するには脱色、脱臭などの精製処理を施す必要があり、その際に抗酸化効果が減少することが多く、充分な効果を有する抽出物を得ることが困難であった。 As a natural substance with high antioxidant properties, herb plants have been used in health foods and cosmetics. However, these plant extracts are strong in color and odor, and need to be subjected to purification treatments such as decoloring and deodorizing in order to be incorporated into cosmetics. It was difficult to obtain an extract having
酵母の菌体抽出液には抗酸化効果があることは既に知られており、特開平8−100175(特許文献1)には、酵母を細胞壁溶解酵素あるいはタンパク質分解酵素により処理し抽出した水溶性の抗酸化作用を有する酵母タンパク質分解物の記載がなされている。 It is already known that the yeast cell extract has an antioxidant effect, and JP-A-8-1000017 (Patent Document 1) discloses a water-soluble extract obtained by treating yeast with a cell wall lytic enzyme or a proteolytic enzyme. There is a description of a yeast protein degradation product having an antioxidative action.
また、培地に植物体を添加して発酵させた組成物を利用するものとして、特開2004−141163(特許文献2)には、モモタマナ(Terminalia catappa)の葉を乳酸菌、酵母を用いて発酵させた組成物が、特開2004−73050(特許文献3)には、ミカン科(Rutaceae)植物及び/又はキク科(Asteraceae)植物を、乳酸菌、酵母を用いて発酵させた発酵組成物、特開2002−335881(特許文献4)には、イチゴ、イチジク、ウメ、ブルーベリー、ラズベリー、リンゴ、キウイ等の果実、あるいは柑橘類の皮を加熱殺菌し、酵母Saccharomyces cerevisiae
を接種して発酵させた組成物が記載されている。
Moreover, as what utilizes the composition fermented by adding the plant body to a culture medium, Unexamined-Japanese-Patent No. 2004-141163 (patent document 2) is made to ferment the leaf of a motama mana (Terminalia catappa) using lactic acid bacteria and yeast. JP-A-2004-73050 (Patent Document 3) discloses a fermented composition obtained by fermenting a Rutaceae plant and / or Asteraceae plant using lactic acid bacteria and yeast, In 2002-335881 (Patent Document 4), fruits such as strawberries, figs, ume, blueberries, raspberries, apples and kiwi, or citrus peels are heat sterilized, and then yeast Saccharomyces cerevisiae.
A composition that has been inoculated and fermented is described.
さらに、培地に植物抽出物を添加して発酵させた組成物を利用するものとして、特開2004−43505(特許文献5)には、グアバ抽出物と、米糠類、大豆類及び炭素源を含む培地に微生物を接種し、発酵培養して得られる米糠・大豆発酵物を含有することを特徴とする発酵組成物が記載されている。 Furthermore, as what uses the composition which added the plant extract to the culture medium and was fermented, Unexamined-Japanese-Patent No. 2004-43505 (patent document 5) contains a guava extract, rice bran, soybeans, and a carbon source. A fermentation composition characterized by containing a rice bran / soybean fermented product obtained by inoculating a culture medium with a microorganism and fermenting culture is described.
特許2618286(特許文献6)には、スイカズラ(金銀花)を添加した培養物の記載がなされている。当該特許は酵母菌を培養した後に、スイカズラなどの植物抽出液を混合して利用するものであり、本発明に記載した金銀花抽出液を酵母菌の培養によって、臭い、色を除去し、かつ、金銀花の有する抗酸化効果を減ずることなく利用できるようにした本願発明とは全く異なるものである。 Japanese Patent No. 2618286 (Patent Document 6) describes a culture to which honeysuckle (gold and silver flowers) is added. The patent uses a mixture of plant extracts such as honeysuckle after culturing yeast, and removes odor and color from the gold and silver flower extract described in the present invention by culturing yeast, and This is completely different from the present invention in which the antioxidant effect of gold and silver flowers can be used without reducing.
特開平5−336953(特許文献7)では、月桂樹、ニンニク、タマネギ、オレガノ、ローズマリー、サルビア、タイム、生姜、クローブ、キャラウェー、松、檜、楠、竹を配合したことを特徴とする微生物培養用培地が記載されている。しかし、記載されている内容は、微生物の中でも細菌類(とりわけ嫌気性菌)には、培養に伴いインドールなどの硫化化合物、酢酸アミル、トリメチルアミンなどの臭気の強い化合物を産生し悪臭を発するものが多いため、上記のような植物体からの抽出物を、消臭物質として培地に添加している。これらの成分は、揮発性を有するため培養中に微量ずつ揮発する。
このため、培養に伴い微生物から産生される成分が、上記の揮発性の成分と反応することにより微生物が産生する悪臭を脱臭することを目的としている。上記特許は、微生物用培養培地と記載されているが、具体的には細菌用培地に関する内容しか記載されておらず、すべての微生物にその効果が適用されると納得できるデータも説明も明細書には記載されていない。また、上記特許の内容は、細菌が代謝する硫化化合物、およびアミン物質を上記の植物抽出物の臭いでマスキングしようとするものであり、植物抽出物の臭い自体を減じようとするものではない。しかし、本願特許は、植物抽出液自体の臭い、色を減じることを目的として、酵母菌の培養培地に植物抽出液を添加してその臭い、色を減じるものである。また、酵母菌は分類上も原核生物である細菌とは異なる真核生物であり、かつ清酒の吟醸講に代表されるように、代謝により硫化化合物、アミン化合のような不快な臭気を出すものではないことは明らかであり、本願特許とは全く異なるものである。
In JP-A-5-336953 (Patent Document 7), a microorganism characterized by blending laurel, garlic, onion, oregano, rosemary, salvia, thyme, ginger, clove, caraway, pine, bamboo shoots, bamboo A culture medium is described. However, what is described is that microorganisms (especially anaerobic bacteria) produce microorganisms (especially anaerobic bacteria) that produce strong odor compounds such as sulfur compounds such as indole, amyl acetate, and trimethylamine, and produce malodors. Since there are many, the extract from the above plant bodies is added to the culture medium as a deodorizing substance. Since these components are volatile, they are volatilized in small amounts during the culture.
For this reason, it aims at deodorizing the malodor which a microbe produces by the component produced from a microorganism accompanying culture | cultivation reacting with said volatile component. Although the above patent is described as a culture medium for microorganisms, it specifically describes only the contents related to the culture medium for bacteria, and the description, description and description that can be accepted when the effect is applied to all microorganisms. Is not listed. In addition, the contents of the above patent are intended to mask sulfur compounds and amine substances that are metabolized by bacteria with the odor of the above plant extract, and are not intended to reduce the odor of the plant extract itself. However, in this patent, for the purpose of reducing the smell and color of the plant extract itself, the plant extract is added to the yeast culture medium to reduce the smell and color. In addition, yeasts are eukaryotes that are different from prokaryotic bacteria in terms of classification, and, as represented by the sake brewing course of sake, give off unpleasant odors such as sulfur compounds and amine compounds. It is clear that this is not the case and is quite different from the patent of the present application.
上記に記載したように培地に各種植物抽出物を添加し、各種微生物を用いて培養した組成物が記載されている。しかしながら、金銀花および女貞子の抽出液を完全合成培地に添加し、Saccharomyces cerevisiae 酵母菌で培養し、培養後の菌体抽出液を利用した抗酸化剤の記載はなされていない。 As described above, a composition in which various plant extracts are added to a medium and cultured using various microorganisms is described. However, there is no description of an antioxidant using the extract of gold and silver flowers and Sadako on a completely synthetic medium, culturing with Saccharomyces cerevisiae yeast, and using the cell extract after the culture.
上述の技術文献のように、各種培地にて微生物を培養した培養組成物を得ているが、いずれも満足いく効果ではなかった。そこで、本願においては、これまでにない高い抗酸化効果を有する培養組成物を開発し、化粧料に応用することを課題とする。 Like the above-mentioned technical literature, although the culture composition which culture | cultivated microorganisms with various culture media was obtained, all were not a satisfactory effect. Therefore, an object of the present application is to develop a culture composition having an unprecedented high antioxidant effect and apply it to cosmetics.
さらに、本発明において培地に添加する植物抽出液は、その植物抽出液単独でもこれまで多くの化粧料に利用されてきた。しかし、いずれも抽出物の色、臭いが強く、脱色、脱臭などの精製を行う必要があり、その際に抗酸化効果も減少することが多く、充分な効果を発揮する化粧料を開発することが困難であった。そこで、本願においては、植物抽出液を酵母菌で発酵させ、その酵母菌体抽出液を利用することで、植物抽出物の色や臭いが無く、かつ高い抗酸化効果を有する化粧料を開発することを課題とする。 Furthermore, the plant extract added to the medium in the present invention has been used in many cosmetics so far, even the plant extract alone. However, the color and smell of the extract are strong, and it is necessary to purify decolorization, deodorization, etc. At that time, the antioxidant effect often decreases, and a cosmetic that exhibits sufficient effects should be developed. It was difficult. Therefore, in the present application, a plant extract is fermented with yeast, and the yeast cell extract is used to develop a cosmetic that does not have the color or odor of the plant extract and has a high antioxidant effect. This is the issue.
完全合成培地に、金銀花抽出液及び/又は女貞子抽出液を加え、Saccharomyces cerevisiae 酵母で培養し、培養終了後、菌体と培養液とに分離し、本培養菌体抽出液を効果成分として用いる。 Gold and silver flower extract and / or Sadako extract are added to the complete synthetic medium, cultured in Saccharomyces cerevisiae yeast, and after completion of the culture, it is separated into cells and culture medium, and the main culture cell extract is used as an effective ingredient. Use.
本発明による金銀花、女貞子の抽出物を添加した培地でSaccharomyces cerevisiae 酵母を培養した培養後の菌体抽出液は、高い抗酸化性物質を含有し、紫外線による細胞の損傷を抑制する作用がある。酵母を用いて植物抽出液を発酵することにより、臭いが少なくかつ、高い抗酸化性物質を含有する酵母菌体抽出液が得られる。さらに、一般的に酵母の培養培地に用いられるペプトン、酵母エキス、および麦芽エキスなどの天然物を配合しない完全合成培地で培養することにより、臭いの無い酵母菌体抽出液を得ることができる。 The cell extract after culturing Saccharomyces cerevisiae yeast in a medium supplemented with extracts of gold and silver flowers and Sadako according to the present invention contains a high antioxidant substance and has an action of suppressing cell damage due to ultraviolet rays. is there. By fermenting a plant extract using yeast, a yeast cell extract containing a low odor and containing a high antioxidant substance can be obtained. Furthermore, an odorless yeast cell extract can be obtained by culturing in a completely synthetic medium not containing natural products such as peptone, yeast extract, and malt extract, which are generally used for yeast culture media.
ところで、紫外線は皮膚内で活性酸素を生成し、表皮細胞にアポトーシスを起こさせると共に、種々のサイトカインを産生しメラニン産生を促進させる。紫外線照射により表皮細胞は傷害され細胞数の減少を招くと共に、表皮の角化が抑制され表皮バリアーの形成が不十分となる。このため、皮膚の水分保持がすくなくなり、かさかさした肌になると共に炎症も起こり易い肌となる。また、真皮の線維芽細胞は、紫外線照射によりコラーゲン・ヒアルロン酸の産生が抑制され、肌のハリ・弾力が低下する。 By the way, ultraviolet rays generate active oxygen in the skin, cause apoptosis in epidermal cells, and produce various cytokines to promote melanin production. Irradiation with ultraviolet rays damages the epidermal cells, leading to a decrease in the number of cells, and suppresses keratinization of the epidermis, resulting in insufficient formation of the epidermal barrier. For this reason, the water | moisture content of a skin becomes sluggish, and it becomes the skin which becomes easy to cause inflammation while becoming a bulky skin. In addition, the production of collagen and hyaluronic acid in dermal fibroblasts is suppressed by ultraviolet irradiation, and the firmness and elasticity of the skin are reduced.
従って、かかるSaccharomyces cerevisiae 酵母菌体抽出液を配合してなる本発明の化粧料は、それら両作用の複合に基づく相乗的効果により、紫外線によるシワ・シミ・タルミなどの皮膚の老化や不健全化の症状の予防或いは改善に多面的かつすぐれた効果を発揮して、皮膚を真に健全で若々しい状態に維持し、改善する効果を有する。又、本発明化粧料で活性成分として用いるSaccharomyces cerevisiae 酵母菌体抽出液は、皮膚に対する刺激性が全くなく、このため本発明の化粧料は生体安全性にも大変すぐれたものである。 Therefore, the cosmetic composition of the present invention comprising the Saccharomyces cerevisiae yeast cell extract is a synergistic effect based on the combination of both of these actions, so that aging and unhealing of skin such as wrinkles, stains and tarmi due to ultraviolet rays are achieved. It has a multifaceted and excellent effect in the prevention or improvement of symptoms, and has the effect of maintaining and improving the skin in a truly healthy and youthful state. In addition, the Saccharomyces cerevisiae yeast cell extract used as an active ingredient in the cosmetics of the present invention has no irritation to the skin, and therefore the cosmetics of the present invention are also excellent in biological safety.
以下、本発明について詳細に説明する。
本発明で用いるSaccharomyces cerevisiae 酵母は市販されているパン酵母、または分譲されているSaccharomyces cerevisiae
に属する酵母であれば使用できる。また、酵母は糖類が存在する自然界からも容易に分離することができるため、植物や土などから分離した酵母でSaccharomyces cerevisiae に属する酵母であれば使用できる。
Hereinafter, the present invention will be described in detail.
The Saccharomyces cerevisiae yeast used in the present invention is a commercially available baker's yeast or a distributed Saccharomyces cerevisiae yeast.
Any yeast belonging to the above can be used. In addition, since yeast can be easily separated from the natural world where saccharides are present, it can be used as long as it is yeast isolated from plants and soils and belonging to Saccharomyces cerevisiae.
培地に添加する金銀花(Lonicera japonica Thunb.)はスイカズラ科スイカズラ属の植物で、別名忍冬とも呼ばれる。春に咲いた白色の花がだんだんと黄色くなるので金色と銀色の花が混じって咲くように見えることに由来している。山野や道端に普通に生える蔓性の植物である。金銀花には、利尿、抗炎症、抗菌作用があって、解熱、解毒、発熱、血痢、伝染性肝炎、化膿性疾患、神経痛、リューマチなどの関節筋骨の疼痛に薬効があるとされ、その花蕾の乾燥物が古くから利用されてきた。スイカズラ属植物はスイカズラ、ウグイスカグラ、ヒョウタンボクをはじめ20種ほどある。がいずれの種類でも利用可能である。 Gold and silver flowers (Lonicera japonica Thunb.) Added to the medium are plants belonging to the genus Honeysuckle family, also known as Shinobifu. This is because the white flowers that bloom in spring gradually become yellow and appear to bloom in a mixture of golden and silver flowers. It is a vine plant that normally grows in the mountains and roadsides. Gold and silver flowers have diuretic, anti-inflammatory and antibacterial effects and are said to be effective for antipyretic, detoxification, fever, diarrhea, contagious hepatitis, purulent disease, neuralgia, rheumatism, etc. The dried flowers are used for a long time. There are about 20 species of honeysuckle genus plants, including honeysuckle, warbler, and gourd. Can be used in any type.
女貞子(Ligustrum lucidum )はモクセイ科イボタノキ属トウネズミモチの果実を乾燥したものである。トウネズミモチは、中国原産の常緑高木で、花期は6〜7月頃で黄白色の花を多数咲かせる。公害に強いことから、公園緑化樹などに利用されている。果実は紫黒色に熟するが、これが女貞子という生薬で強壮作用があるといわれている。冬でも葉が青いことから、様子を貞女になぞらえて女貞といわれている。含有成分としては、オレアノール酸、ウルソール酸、マンニトールなどが知られており、古くから利用されてきた。 Sadako (Ligustrum lucidum) is a dried fruit of the genus Coleoptera spp. The Japanese hornworm is an evergreen tree native to China, and the flowering period is from June to July, and many yellowish white flowers bloom. Because it is resistant to pollution, it is used for park greening trees. The fruit ripens purple-black, but this is said to have a tonic effect with herbal medicine called Sadako. Even in winter, the leaves are blue. As components, oleanolic acid, ursolic acid, mannitol and the like are known and have been used for a long time.
本発明に用いる金銀花および女貞子抽出液の調製法は特に限定されないが、例えば種々の適当な有機溶媒を用いて低温下から加温下で抽出することができる。抽出溶媒としては、例えば、水;メチルアルコール、エチルアルコール等の低級1価アルコール;グリセリン、プロピレングリコール、1、3−ブチレングリコール等の液状多価アルコール;アセトン、メチルエチルケトン等のケトン;酢酸エチルなどのアルキルエステル;ベンゼン、ヘキサン等の炭化水素;ジエチルエーテル等のエーテル類;ジクロルメタン、クロロホルム等のハロゲン化アルカン等の1種または2 種以上を用いることが出来る。そのうち、水、エチルアルコール、1、3−ブチレングリコールの1種または2種以上の混合溶媒が特に好適に示される。 The method for preparing the gold and silver flower and Sadako extract used in the present invention is not particularly limited, and for example, it can be extracted from a low temperature to a high temperature using various appropriate organic solvents. Examples of the extraction solvent include water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; liquid polyhydric alcohols such as glycerin, propylene glycol, and 1,3-butylene glycol; ketones such as acetone and methyl ethyl ketone; and ethyl acetate. One kind or two or more kinds of alkyl esters; hydrocarbons such as benzene and hexane; ethers such as diethyl ether; halogenated alkanes such as dichloromethane and chloroform can be used. Among them, water, ethyl alcohol, and one or more mixed solvents of 1,3-butylene glycol are particularly preferable.
また抽出方法は金銀花或いは女貞子をそのまま、あるいは粉砕したものを質量比で2〜1000倍量、特に5〜100倍量の溶媒を用いることが出来る。常温抽出の場合には、0℃以上、特に20℃〜40℃で1時間以上、特に3〜7日間行うのが好適である。また、60〜100℃で0.5〜24時間、加熱抽出しても良い。 Further, the extraction method can use a solvent of 2 to 1000 times, particularly 5 to 100 times the amount of gold-silver-flower or Sadako as it is or after pulverization. In the case of normal temperature extraction, it is preferable to carry out at 0 ° C. or higher, particularly 20 ° C. to 40 ° C. for 1 hour or longer, particularly 3 to 7 days. Moreover, you may heat-extract at 60-100 degreeC for 0.5 to 24 hours.
以上のような条件で得られる金銀花、女貞子抽出液は、ろ過等の処理をして溶液のまま用いても良いが、更に必要により、濃縮、粉末化したものを適宜使い分けて用いることが出来る。 The gold and silver flower and Sadako extracts obtained under the above conditions may be used as they are after filtration or the like, but if necessary, concentrated and powdered ones may be used appropriately. I can do it.
酵母菌は一般的にグルコースに代表される炭素源と、ペプトンに代表されるペプチド類からなる窒素源、酵母エキスに代表される微量ビタミン類、ミネラル類などの栄養素を含有する物質が含まれていれば培養が可能である。一般的には天然物からなるYM(Yeast-Malt)培地、YPD(Yeast-Polypeptone-Dextrose)培地などが用いられている。しかしながら、酵母菌はこれら天然物を配合した培地で培養すると、不快な臭いを有する培養物になることが知られている。 Yeasts generally contain substances containing nutrients such as carbon sources typified by glucose, nitrogen sources consisting of peptides typified by peptones, trace vitamins typified by yeast extracts, and minerals. Culture is possible. Generally, a YM (Yeast-Malt) medium, a YPD (Yeast-Polypeptone-Dextrose) medium, or the like made of a natural product is used. However, it is known that yeasts become a culture having an unpleasant odor when cultured in a medium containing these natural products.
そこで、本特許においては天然物を配合しない合成培地を基本培地としている。
培地組成としては、最低限の炭素源と窒素源とリン源を含んでいれば良く、炭素源としては、リボース、アラビノース、キシロース、グルコース、フルクトース、マンノース、ガラクトース、ラムノース、等の単糖類、シュクロース、マルトース、ラクトース、トレハロース、セロビオース、等の二糖類、またラフィノース、マルトトリオース等の三糖類を用いることができる。これらから1種以上含有していれば良い。
窒素源としては、尿素、硝酸塩として硝酸カリウム、硝酸ナトリウム、硝酸カルシウム、アンモニウム塩として硫酸アンモニウム、塩化アンモニウム、また、アミノ酸として、トリプトファン、
リシン、メチオニン、フェニルアラニン、トレオニン、バリン、イソロイシン、ロイシン、ヒスチジン、アラニン、アルギニン、アスパラギン、セリン、アスパラギン酸、システイン、グルタミン、グルタミン酸、グリシン、プロリン、チロシン等の窒素含有化合物を用いることができ、これらから1種以上含有していれば良い。
リン源としては、リン酸塩を用いることが出来、リン酸1水素カリウム、リン酸2水素カリウム、リン酸アンモニウムを用いることができ、これらから1種以上含有していれば良い。
Therefore, in this patent, a synthetic medium not containing a natural product is used as a basic medium.
The medium composition may include a minimum carbon source, nitrogen source, and phosphorus source. Examples of the carbon source include ribose, arabinose, xylose, glucose, fructose, mannose, galactose, rhamnose, etc. Disaccharides such as claus, maltose, lactose, trehalose and cellobiose, and trisaccharides such as raffinose and maltotriose can be used. One or more of these may be contained.
Nitrogen sources include urea, potassium nitrate as nitrate, sodium nitrate, calcium nitrate, ammonium sulfate as ammonium sulfate, ammonium chloride, amino acid as tryptophan,
Nitrogen-containing compounds such as lysine, methionine, phenylalanine, threonine, valine, isoleucine, leucine, histidine, alanine, arginine, asparagine, serine, aspartic acid, cysteine, glutamine, glutamic acid, glycine, proline, tyrosine, etc. can be used. As long as it contains at least one kind.
As the phosphorus source, phosphate can be used, and potassium monohydrogen phosphate, potassium dihydrogen phosphate, and ammonium phosphate can be used, and one or more of these may be contained.
合成培地の基本培地としては、前記炭素源と窒素源とリン源を含んでいれば十分であるが、その他にビタミン源、ミネラル源を追加することも可能である。
ビタミン源としては、例えばビオチン、チアミン(ビタミンB1)、リボフラビン、ピリドキシン(ビタミンB6)、パントテン酸、アスコルビン酸、ヨウ酸、シアノコバラミン、イノシトール、ニコチン酸、コリン、カルニチン、パラアミノ安息香酸、ニコチンアミドアデニンジヌクレオチド等を用いることができる。
ミネラル源としては、カリウム、カルシウム、マグネシウム、イオウ、鉄、マンガン、亜鉛、ホウ素、銅、モリブデン、ナトリウム、ヨウ素、コバルト等が挙げられ、これらを供給できる具体的な成分としては、例えば、硝酸カルシウム、塩化カリウム、塩化カルシウム、硫酸マグネシウム、硫酸ナトリウム、硫酸第一鉄、硫酸第二鉄、硫酸マンガン、硫酸亜鉛、ホウ酸、硫酸銅、モリブデン酸ナトリウム、三酸化モリブデン、ヨウ化カリウム、塩化コバルト等の化合物を用いることができる。
The basic medium of the synthetic medium is sufficient as long as it contains the carbon source, nitrogen source and phosphorus source, but it is also possible to add a vitamin source and a mineral source.
Examples of vitamin sources include biotin, thiamine (vitamin B1), riboflavin, pyridoxine (vitamin B6), pantothenic acid, ascorbic acid, iodic acid, cyanocobalamin, inositol, nicotinic acid, choline, carnitine, paraaminobenzoic acid, nicotinamide adenidine Nucleotides and the like can be used.
Examples of mineral sources include potassium, calcium, magnesium, sulfur, iron, manganese, zinc, boron, copper, molybdenum, sodium, iodine, cobalt, and the like. Specific components that can supply these include, for example, calcium nitrate. , Potassium chloride, calcium chloride, magnesium sulfate, sodium sulfate, ferrous sulfate, ferric sulfate, manganese sulfate, zinc sulfate, boric acid, copper sulfate, sodium molybdate, molybdenum trioxide, potassium iodide, cobalt chloride, etc. These compounds can be used.
本発明においては、上記成分を適宜組み合わせて基本培地とする。
勿論、天然成分を含まない合成培地であるCzapek培地、Burkholder培地、YNB(Yeast Nitrogen Base)培地を基本培地とすることも出来る。
In the present invention, the above components are appropriately combined to form a basic medium.
Of course, a Czapek medium, a Burkholder medium, or a YNB (Yeast Nitrogen Base) medium, which is a synthetic medium not containing natural components, can be used as a basic medium.
前記以外の培地組成であっても、酵母菌が資化・増殖できる物質であれば、本発明に適用されるのは勿論である。さらに、培地には水或いは水と低級アルコール類(メタノール、エタノール、プロパノールなど)もしくはグリコール類(エチレングリコール、プロピレングリコール、1,3−ブチレングリコール、グリセリンなど)との混液等を添加して基本培地としても良い。 Of course, the medium composition other than the above can be applied to the present invention as long as it is a substance that can be assimilated and grown by yeast. Furthermore, the basic medium is prepared by adding water or a mixture of water and lower alcohols (methanol, ethanol, propanol, etc.) or glycols (ethylene glycol, propylene glycol, 1,3-butylene glycol, glycerin, etc.) to the medium. It is also good.
本発明に用いられる培地は、前記基本培地に、金銀花抽出液及び/又は女貞子抽出液を加えたものを培地として利用する。 As the medium used in the present invention, a medium obtained by adding the gold and silver flower extract and / or Sadako extract to the basic medium is used as the medium.
前記の培地は、これを培養工程に供する前に、殺菌を行って培養の障害となる雑菌を除去する。この場合殺菌除去方法としては、培地の組成物を予め殺菌した上、無菌水等の無菌媒体に懸濁する方法を用いてもよく、又培地の組成物を媒体に懸濁した後、懸濁液を加熱殺菌する方法を用いるようにしてもよい。加熱殺菌法としては、懸濁液を120〜130℃で10〜20分間加熱するオートクレーブ殺菌法や、懸濁液を80〜90℃に60〜120分間保持することを1日1回2〜3日間繰り返す間断殺菌法が一般に用いられる。 The above-mentioned medium is sterilized to remove various germs that hinder culture before being subjected to the culture step. In this case, the sterilization removal method may be a method in which the medium composition is sterilized in advance and suspended in a sterile medium such as sterile water, or the medium composition is suspended in the medium and then suspended. You may make it use the method of heat-sterilizing a liquid. Examples of the heat sterilization method include an autoclave sterilization method in which the suspension is heated at 120 to 130 ° C. for 10 to 20 minutes, and holding the suspension at 80 to 90 ° C. for 60 to 120 minutes once to 2-3 times a day. An intermittent sterilization method is generally used for repeated days.
次に、この無菌化した培地を培養タンクに入れ、これにSaccharomyces cerevisiae 酵母を植菌して培養を行う。Saccharomyces cerevisiae 酵母の接種量は107〜108個/mLが適量である。接種量が上記の範囲より多くなっても培養の進行時間は殆ど変わらず、一方上記の範囲より少なくなると培養完了までに長時間を要することとなって好ましくない。 Next, the sterilized medium is placed in a culture tank, and Saccharomyces cerevisiae yeast is inoculated into the culture tank and cultured. The appropriate amount of Saccharomyces cerevisiae yeast inoculation is 10 7 to 10 8 cells / mL. Even if the inoculation amount is larger than the above range, the culturing time hardly changes. On the other hand, if the inoculation amount is smaller than the above range, it takes a long time to complete the cultivation, which is not preferable.
培養温度は一般に5〜50℃の範囲、好ましくはSaccharomyces cerevisiae 酵母の生育至適温度である20〜35℃の範囲である。培養日数は、至適温度に於いて一般に1〜10日、好ましくは2〜5日の範囲である。培養日数が上記の一般的範囲より短くなると培養が十分に行われず培養物の有効性が低下する傾向にあり、一方10日を越えて長くしても有効性のそれ以上の上昇は認められないだけでなく、Saccharomyces cerevisiae酵母菌体への色や培養臭の増加が生ずることとなっていずれも好ましくない。 The culture temperature is generally in the range of 5 to 50 ° C., preferably in the range of 20 to 35 ° C., which is the optimum temperature for growth of Saccharomyces cerevisiae yeast. The number of culture days is generally in the range of 1 to 10 days, preferably 2 to 5 days at the optimum temperature. When the culture days are shorter than the above general range, the culture is not sufficiently performed, and the effectiveness of the culture tends to decrease. On the other hand, if the culture days are longer than 10 days, no further increase in effectiveness is observed. Not only that, but also an increase in color and culture odor to Saccharomyces cerevisiae yeast cells is undesirable.
以上の培養が終ったならば、Saccharomyces cerevisiae 酵母菌体と培養液を分離させ培養の進行を止める。培養物はろ過、或いは遠心分離などの固液分離手段によって培養液を分取し、酵母菌体と分離する。得られたSaccharomyces cerevisiae 酵母は、菌体中の抗酸化性物質を抽出するために、水と有機溶媒の混液などで抽出する。このとき用いる有機溶媒は特に限定されないが、例えば種々の適当な有機溶媒を用いて低温下から加温下で抽出することができる。抽出溶媒としては、例えば、水;メチルアルコール、エチルアルコール等の低級1価アルコール;グリセリン、プロピレングリコール、1、3−ブチレングリコール等の液状多価アルコール;アセトン、メチルエチルケトン等のケトン;酢酸エチルなどのアルキルエステル;ベンゼン、ヘキサン等の炭化水素;ジエチルエーテル等のエーテル類;ジクロルメタン、クロロホルム等のハロゲン化アルカン等の1種または2 種以上を用いることが出来る。そのうち、水、エチルアルコール、1、3−ブチレングリコールの1種または2種以上の混合溶媒が特に好適に示される。また、酵母菌体の細胞壁を分解させるβ-グルカナーゼなどの酵素を作用させる方法や、酸、アルカリによる加水分解により、菌体内成分を抽出する方法が可能である。 When the above culture is completed, the yeast cells and the culture medium are separated from the Saccharomyces cerevisiae yeast and the progress of the culture is stopped. The culture is separated from yeast cells by separating the culture solution by solid-liquid separation means such as filtration or centrifugation. The obtained Saccharomyces cerevisiae yeast is extracted with a mixture of water and an organic solvent in order to extract an antioxidant substance in the microbial cells. Although the organic solvent used at this time is not specifically limited, For example, it can extract under low temperature from warm using various suitable organic solvents. Examples of the extraction solvent include water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; liquid polyhydric alcohols such as glycerin, propylene glycol, and 1,3-butylene glycol; ketones such as acetone and methyl ethyl ketone; and ethyl acetate. One kind or two or more kinds of alkyl esters; hydrocarbons such as benzene and hexane; ethers such as diethyl ether; halogenated alkanes such as dichloromethane and chloroform can be used. Among them, water, ethyl alcohol, and one or more mixed solvents of 1,3-butylene glycol are particularly preferable. In addition, a method in which an enzyme such as β-glucanase that degrades the cell wall of yeast cells is allowed to act, or a method in which bacterial cell components are extracted by hydrolysis with acid or alkali is possible.
本発明のSaccharomyces cerevisiae 酵母の培養後の菌体抽出液を配合してなる化粧料としては、例えば乳液、クリーム、ローション、エッセンス、パック、洗顔料などの基礎化粧料、口紅、ファンデーション、リキッドファンデーション、メイクアッププレスドパウダーなどのメイクアップ化粧料、洗顔料、ボディーシャンプー、石けんなどの清浄用化粧料、さらには浴剤等が挙げられるが、勿論これらに限定されるものではない。 Examples of cosmetics obtained by blending the cell extract after culturing the yeast of the Saccharomyces cerevisiae of the present invention include basic cosmetics such as emulsions, creams, lotions, essences, packs, facial cleansers, lipsticks, foundations, liquid foundations, Examples include makeup cosmetics such as makeup pressed powder, cleansing cosmetics such as facial cleansers, body shampoos, and soaps, and bath agents, but are not limited thereto.
本発明の化粧料中に於けるSaccharomyces cerevisiae 酵母の培養後の菌体抽出液の配合量は、菌体抽出液の蒸発残分に換算して0.0001〜10質量%、好ましくは0.01〜1質量%の範囲である。 The blending amount of the bacterial cell extract after culturing the Saccharomyces cerevisiae yeast in the cosmetic of the present invention is 0.0001 to 10% by mass, preferably 0.01% in terms of the evaporation residue of the bacterial cell extract. It is in the range of ˜1% by mass.
本発明の化粧料には、上記の必須成分の他に、通常化粧料に用いられる配合成分、例えば油性成分、界面活性剤、保湿剤、増粘剤、防腐・殺菌剤、粉体成分、紫外線吸収剤、色素、香料等を必要に応じて適宜配合することができる。 In addition to the above-mentioned essential ingredients, the cosmetics of the present invention include compounding ingredients usually used in cosmetics, such as oily ingredients, surfactants, moisturizers, thickeners, antiseptic / disinfectants, powder ingredients, ultraviolet rays. Absorbers, pigments, fragrances and the like can be appropriately blended as necessary.
ここで、油性成分としては、例えばオリーブ油、ホホバ油、ヒマシ油、大豆油、米油、米胚芽油、ヤシ油、パーム油、カカオ油、メドウフォーム油、シアーバター、ティーツリー油、アボガド油、マカデミアナッツ油、植物由来スクワランなどの植物由来の油脂類;ミンク油、タートル油などの動物由来の油脂類;ミツロウ、カルナウバロウ、ライスワックス、ラノリンなどのロウ類;流動パラフィン、ワセリン、パラフィンワックス、スクワランなどの炭化水素類;ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、イソステアリン酸、cis−11−エイコセン酸などの脂肪酸類;ラウリルアルコール、セタノール、ステアリルアルコールなどの高級アルコール類;ミリスチン酸イソプロピル、パルミチン酸イソプロピル、オレイン酸ブチル、2−エチルヘキシルグリセライド、高級脂肪酸オクチルドデシル(ステアリン酸オクチルドデシル等)などの合成エステル類及び合成トリグリセライド類等が挙げられる。 Here, as the oil component, for example, olive oil, jojoba oil, castor oil, soybean oil, rice oil, rice germ oil, palm oil, palm oil, cacao oil, meadow foam oil, sheer butter, tea tree oil, avocado oil, Oils derived from plants such as macadamia nut oil and plant-derived squalane; Fats derived from animals such as mink oil and turtle oil; waxes such as beeswax, carnauba wax, rice wax, lanolin; liquid paraffin, petrolatum, paraffin wax, squalane, etc. Hydrocarbons; fatty acids such as myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid, cis-11-eicosenoic acid; higher alcohols such as lauryl alcohol, cetanol, stearyl alcohol; isopropyl myristate, palmitic acid Isopropyl, me Butyl phosphate, 2-ethylhexyl glycerides, higher fatty acid octyldodecyl (octyl stearate dodecyl and the like), and the synthetic esters and synthetic triglycerides such like.
界面活性剤としては,例えばポリオキシエチレンアルキルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビトール脂肪酸エステルなどの非イオン界面活性剤;脂肪酸塩、アルキル硫酸塩、アルキルベンゼンスルホン酸塩、ポリオキシエチレンアルキルエーテル硫酸塩、ポリオキシエチレン脂肪酸アミン硫酸塩、ポリオキシエチレンアルキルフェニルエーテル硫酸塩、ポリオキシエチレンアルキルエーテル燐酸塩、α−スルホン化脂肪酸アルキルエステル塩、ポリオキシエチレンアルキルフェニルエーテル燐酸塩などのアニオン界面活性剤;第四級アンモニウム塩、第一級〜第三級脂肪酸アミン塩、トリアルキルベンジルアンモニウム塩、アルキルピリジニウム塩、2−アルキル−1−アルキル−1−ヒドロキシエチルイミダゾリニウム塩、N,N−ジアルキルモルフォルニウム塩、ポリエチレンポリアミン脂肪酸アミド塩などのカチオン界面活性剤;N,N−ジメチル−N−アルキル−N−カルボキシメチルアンモニオベタイン、N,N,N−トリアルキル−N−アルキレンアンモニオカルボキシベタイン、N−アシルアミドプロピル−N′,N′−ジメチル−N′−β−ヒドロキシプロピルアンモニオスルホベタインなどの両性界面活性剤等を使用することができる。 Examples of the surfactant include polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxyethylene Nonionic surfactants such as oxyethylene sorbitol fatty acid esters; fatty acid salts, alkyl sulfates, alkylbenzene sulfonates, polyoxyethylene alkyl ether sulfates, polyoxyethylene fatty acid amine sulfates, polyoxyethylene alkyl phenyl ether sulfates, Polyoxyethylene alkyl ether phosphates, α-sulfonated fatty acid alkyl ester salts, polyoxyethylene alkyl phenyl ether phosphates, etc. ON surfactant: quaternary ammonium salt, primary to tertiary fatty acid amine salt, trialkylbenzylammonium salt, alkylpyridinium salt, 2-alkyl-1-alkyl-1-hydroxyethylimidazolinium salt, N N, N-dimethyl-N-alkyl-N-carboxymethylammoniobetaine, N, N, N-trialkyl-N-, N, N-dimethyl-N-alkyl-N-carboxymethylammoniobetaine Amphoteric surfactants such as alkylene ammoniocarboxybetaine and N-acylamidopropyl-N ′, N′-dimethyl-N′-β-hydroxypropylammoniosulfobetaine can be used.
保湿剤としては、例えばグリセリン、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、ポリエチレングリコールなどのグリコール類、マルチトール、ソルビトール、キシリトール、トレハロース、グルコース等の糖類、ピロリドンカルボン酸ナトリウム、乳酸菌発酵米、ムコ多糖類(例えば、ヒアルロン酸及びその誘導体、コンドロイチン及びその誘導体、ヘパリン及びその誘導体など)、エラスチン及びその誘導体、コラーゲン及びその誘導体、加水分解シルク蛋白質、NMF関連物質、乳酸、尿素、高級脂肪酸オクチルドデシル、フィトステロール、大豆リン脂質、イソステアリン酸コレステリル、海藻抽出物、各種アミノ酸及びそれらの誘導体等が挙げられる。 Examples of humectants include glycols such as glycerin, propylene glycol, dipropylene glycol, 1,3-butylene glycol, and polyethylene glycol, sugars such as maltitol, sorbitol, xylitol, trehalose, glucose, sodium pyrrolidonecarboxylate, and lactic acid bacteria fermentation. Rice, mucopolysaccharide (eg, hyaluronic acid and its derivatives, chondroitin and its derivatives, heparin and its derivatives), elastin and its derivatives, collagen and its derivatives, hydrolyzed silk protein, NMF related substances, lactic acid, urea, high grade Examples include fatty acid octyldodecyl, phytosterol, soybean phospholipid, cholesteryl isostearate, seaweed extract, various amino acids, and derivatives thereof.
増粘剤としては、例えばアルギン酸、寒天、カラギーナン、フコイダン、ファーセララン等の褐藻、緑藻或いは紅藻由来成分、ビャッキュウ抽出物、ペクチン、ローカストビーンガム、アロエ多糖体等の多糖類、キサンタンガム、トラガントガム、グアーガム等のガム類、カルボキシメチルセルロース、ヒドロキシエチルセルロース等のセルロース誘導体、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、アクリル酸・メタクリル酸共重合体等の合成高分子類;ヒアルロン酸及びその誘導体、ポリグルタミン酸及びその誘導体、グルコシルトレハロースと加水分解水添デンプンを主体とする糖化合物等が挙げられる。 Examples of thickeners include, for example, brown algae such as alginic acid, agar, carrageenan, fucoidan, and fartheraran, green algae or red algae-derived components, beech extract, pectin, locust bean gum, polysaccharides such as aloe polysaccharide, xanthan gum, tragacanth gum, guar gum Synthetic polymers such as gums such as carboxymethylcellulose, hydroxyethylcellulose, etc., polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymer, acrylic acid / methacrylic acid copolymer; hyaluronic acid and its derivatives, polyglutamic acid and its Examples thereof include sugar compounds mainly composed of derivatives, glucosyl trehalose and hydrolyzed hydrogenated starch.
防腐・殺菌剤としては、例えばパラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ブチルなどのパラオキシ安息香酸エステル類;フェノキシエタノール、ジクロロフェン、ヘキサクロロフェン、塩酸クロルヘキシジン、塩化ベンザルコニウム、サリチル酸、エタノール、ウンデシレン酸、フェノール類、ジャーマル(イミダゾデイニールウレア)、1,2−ペンタンジオール、各種精油類、樹皮乾留物、プロポリスエキス等がある。 Examples of the antiseptic / bactericidal agent include paraoxybenzoates such as methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, and butyl paraoxybenzoate; phenoxyethanol, dichlorophene, hexachlorophene, chlorhexidine hydrochloride, benzalkonium chloride , Salicylic acid, ethanol, undecylenic acid, phenols, jarmal (imidazodenyl urea), 1,2-pentanediol, various essential oils, bark distillate, propolis extract and the like.
粉体成分としては、例えばセリサイト、酸化チタン、タルク、カオリン、ベントナイト、酸化亜鉛、炭酸マグネシウム、酸化マグネシウム、酸化ジルコニウム、硫酸バリウム、無水ケイ酸、雲母、6−又は12−ナイロンパウダー、ポリエチレンパウダー、シルクパウダー、セルロース系パウダー等がある。 Examples of the powder component include sericite, titanium oxide, talc, kaolin, bentonite, zinc oxide, magnesium carbonate, magnesium oxide, zirconium oxide, barium sulfate, silicic anhydride, mica, 6- or 12-nylon powder, polyethylene powder. , Silk powder, cellulosic powder and the like.
紫外線吸収剤としては、例えばパラアミノ安息香酸エチル、パラジメチルアミノ安息香酸エチルヘキシル、サリチル酸アミル及びその誘導体、パラメトキシ桂皮酸2−エチルヘキシル、桂皮酸オクチル、オキシベンゾン、2,4−ジヒドロキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸塩、4−ターシャリーブチル−4−メトキシベンゾイルメタン、2−(2−ヒドロキシ−5−メチルフェニル)ベンゾトリアゾール、ウロカニン酸、ウロカニン酸エチル、アロエ抽出物等がある。 Examples of the ultraviolet absorber include ethyl paraaminobenzoate, ethylhexyl paradimethylaminobenzoate, amyl salicylate and derivatives thereof, 2-ethylhexyl paramethoxycinnamate, octyl cinnamate, oxybenzone, 2,4-dihydroxybenzophenone, 2-hydroxy-4 -Methoxybenzophenone-5-sulfonate, 4-tertiarybutyl-4-methoxybenzoylmethane, 2- (2-hydroxy-5-methylphenyl) benzotriazole, urocanic acid, ethyl urocanate, aloe extract, etc. .
抗酸化剤としては、例えばスーパーオキシドディスムターゼ(Superoxide dismutase)、カタラーゼなどの生体内活性酸素分解酵素、ビタミンE、ビタミンDなどのビタミン類及びその誘導体、ブチルヒドロキシアニソール、ブチルヒドロキシトルエン、没食子酸プロピル、ユビデカキノン(ユビキノン)、ルチン、ルチングルコシド、γ−オリザノール等がある。 Antioxidants include, for example, superoxide dismutase, bioactive oxygen-degrading enzymes such as catalase, vitamins such as vitamin E and vitamin D and derivatives thereof, butylhydroxyanisole, butylhydroxytoluene, propyl gallate, There are ubidecaquinone (ubiquinone), rutin, rutin glucoside, γ-oryzanol and the like.
さらに必要ならば、本発明で用いる発酵物の作用効果及び特長を損なわない範囲で、他の活性成分(美白剤、皮膚老化防止・肌荒れ改善剤、抗炎症剤等)を配合してもよく、かかるものとしては、例えば美白剤であれば、トラネキサム酸及びその誘導体、t−シクロアミノ酸誘導体、コウジ酸及びその誘導体、アスコルビン酸及びその誘導体、ハイドロキノン誘導体、エラグ酸及びその誘導体、レゾルシノール誘導体、胎盤抽出物、システイン、ソウハクヒ抽出物、ユキノシタ抽出物、ハマメリス抽出物、イタドリ抽出物、甘草抽出物、ゲンノショウコ抽出物、ナツメ抽出物、シャクヤク抽出物、トウキ抽出物、モモ抽出物、緑藻類、紅藻類又は褐藻類の海藻の抽出物、リノール酸及びその誘導体もしくは加工物(例えばリノール酸メントールエステルなど)、2,5−ジヒドロキシ安息香酸誘導体等が、皮膚老化防止・肌荒れ改善成分であれば、動物又は魚由来のコラーゲン及びその誘導体、エラスチン及びその誘導体、セラミドなどの細胞間脂質、胎盤抽出物、ニコチン酸及びその誘導体、グリチルリチン酸及びその誘導体(ジカリウム塩等)、t−シクロアミノ酸誘導体、ビタミンA前駆体、ビタミンA及びその誘導体、ビタミンE及びその誘導体、アラントイン、α−ヒドロキシ酸類、ジイソプロピルアミンジクロロアセテート、γ−アミノ−β−ヒドロキシ酪酸、コエンザイムQ−10、アデノシン、α−リポ酸、ピコリン、カルニチン及びその誘導体、ゲンチアナエキス、甘草エキス、ハトムギエキス、カミツレエキス、ニンジンエキス、アロエエキスなどの生薬抽出エキス、米発酵エキス、緑藻類、紅藻類又は褐藻類の海藻の抽出物、ソウハクヒエキス、ブナ抽出物、キダチアロエ抽出物、マンネンロウ抽出物、イチョウ抽出物、スギナ抽出物、ベニバナ抽出物、オタネニンジン抽出物、セイヨウニワトコ抽出物、ハゴロモグサ抽出物、レンゲ抽出物、マンゴー抽出物、卵殻膜抽出タンパク質、デオキシリボ核酸カリウム塩、紫蘭根抽出物、ムラサキシキブ抽出物、イネ抽出物等が、又抗炎症成分であれば、例えばグアイアズレンスルホン酸ナトリウム、グアイアズレンスルホン酸エチルなどのアズレン誘導体、グリチルリチン酸ジカリウム、グリチルレチン酸ステアリルなどのグリチルリチン酸誘導体、アラントイン、カンゾウ抽出物、クジン抽出物、シャクヤク抽出物、ボタンピ抽出物、レンギョウ抽出物、リュウタン抽出物、トウキンセンカ抽出物、パセリ抽出物、オトギリソウ抽出物等が挙げられる。 Furthermore, if necessary, other active ingredients (whitening agent, skin aging prevention / rough skin improvement agent, anti-inflammatory agent, etc.) may be blended within the range that does not impair the effects and features of the fermented product used in the present invention. Examples of such a whitening agent include tranexamic acid and its derivatives, t-cycloamino acid derivatives, kojic acid and its derivatives, ascorbic acid and its derivatives, hydroquinone derivatives, ellagic acid and its derivatives, resorcinol derivatives, placental extraction , Cysteine, Sakuhakuhi extract, Yukinoshita extract, Hamamelis extract, Itadori extract, Licorice extract, Gentian extract, Jujube extract, Peonies extract, Sugi extract, Peach extract, Green algae, Red algae or Brown algae Seaweed extracts, linoleic acid and its derivatives or processed products (eg menthol linoleate) Ester, etc.), 2,5-dihydroxybenzoic acid derivatives, etc., are components for preventing skin aging and improving rough skin, collagen derived from animals or fish and derivatives thereof, elastin and derivatives thereof, intercellular lipids such as ceramide, placenta extraction Nicotinic acid and derivatives thereof, glycyrrhizic acid and derivatives thereof (dipotassium salt, etc.), t-cycloamino acid derivatives, vitamin A precursor, vitamin A and derivatives thereof, vitamin E and derivatives thereof, allantoin, α-hydroxy acids, diisopropyl Amine dichloroacetate, γ-amino-β-hydroxybutyric acid, coenzyme Q-10, adenosine, α-lipoic acid, picoline, carnitine and its derivatives, gentian extract, licorice extract, pearl barley extract, chamomile extract, carrot extract, aloe extract, etc. Herbal medicine extract , Rice fermented extract, green algae, red algae or brown algae seaweed extract, Sakuhakuhi extract, beech extract, beetle aloe extract, mannenrou extract, ginkgo biloba extract, horsetail extract, safflower extract, ginseng extract, If it is an anti-inflammatory component such as elderberry extract, garlic extract, lotus extract, mango extract, eggshell membrane extract protein, deoxyribonucleic acid potassium salt, purple orchid root extract, purple extract, rice extract, etc. For example, azulene derivatives such as sodium guaiazulene sulfonate and ethyl guaiazulene sulfonate, glycyrrhizic acid derivatives such as dipotassium glycyrrhizinate and stearyl glycyrrhetinate, allantoin, licorice extract, cucumber extract, peonies extract, button pie extract, forsythia extract Ryuutan extract, tow calendula extract, parsley extract, Hypericum extract, and the like.
以下、本発明における酵母菌体抽出液の効果試験の実施例を示す。さらに、その酵母菌体抽出液を用いた皮膚組成物への応用処方例等について述べるが、ここに記載された実施例に限定されるものではない。なお、以下に於いて、部はすべて質量部を、又%はすべて質量%を意味する。 Hereinafter, the Example of the effect test of the yeast cell extract in this invention is shown. Furthermore, although the example of application prescription etc. to the skin composition using the yeast cell extract is described, it is not limited to the Example described here. In the following, all parts are parts by mass, and all% are% by mass.
Saccharomyces cerevisiae 酵母の採取方法
市販されているパン酵母(日清スパーカメリア・ドライイースト:日清フーズ(株))を購入し、120℃で15分間滅菌したYM培地100mlを添加した三角フラスコに0.1g懸濁し、28℃、150rpmで3日間回転培養を行った。懸濁液を1白金耳取り、YM寒天培地上で引き伸ばして単独コロニーを得、これを以下の実験に使用した。
以下、培地組成においてg/L等とあるのは、各成分を該当g計量し、精製水で1Lにしたという意味である。
<YM培地>
ペプトン5g/L、酵母エキス3g/L、麦芽エキス3g/L、グルコース10g/L
<YM寒天培地>
YM培地に寒天20g/Lを添加し、加熱溶解して作成。
Saccharomyces cerevisiae Yeast Collection Method A commercially available baker's yeast (Nisshin Supercamellia Dry Yeast: Nisshin Foods Co., Ltd.) was purchased and added to an Erlenmeyer flask containing 100 ml of YM medium sterilized at 120 ° C. for 15 minutes. 1 g of the suspension was suspended, and rotational culture was performed at 28 ° C. and 150 rpm for 3 days. One platinum loop was taken from the suspension and stretched on a YM agar medium to obtain a single colony, which was used in the following experiment.
Hereinafter, “g / L” or the like in the medium composition means that each g was weighed and made 1 L with purified water.
<YM medium>
Peptone 5g / L, yeast extract 3g / L, malt extract 3g / L, glucose 10g / L
<YM agar>
Prepared by adding 20 g / L agar to YM medium and dissolving with heating.
金銀花、女貞子抽出液の調製
金銀花抽出液は、漢方薬として市販されている金銀花乾燥物を購入し、粉砕機で粉砕した。粉砕物10gに精製水90gを加え、80℃で2時間加熱抽出した。抽出液は遠心分離器で上澄み液を取り、金銀花抽出液とした。女貞子抽出液は漢方薬として市販されている女貞子を購入し、以下金銀花抽出液と同じ処理を行い、女貞子抽出液を得た。尚、得られた抽出液の濃度は、金銀花抽出液は蒸発残分に換算して4.0W/V%、女貞子抽出液は、蒸発残分に換算して2.8W/V%であった。
Preparation of gold and silver flower and Sadako extract The gold and silver flower extract was obtained by purchasing a gold and silver flower dried product marketed as a Chinese medicine and pulverizing with a pulverizer. 90 g of purified water was added to 10 g of the pulverized product, and the mixture was extracted by heating at 80 ° C. for 2 hours. The supernatant was extracted with a centrifuge to obtain a gold and silver flower extract. The Sadako extract was purchased as a Chinese herbal medicine, and the same treatment as the gold and silver flower extract was performed to obtain a Sadako extract. The concentration of the resulting extract is 4.0 W / V% in terms of evaporation residue for gold and silver flower extract, and 2.8 W / V% for Sadako extract in terms of evaporation residue. there were.
酵母の培養と培地の調製
培地はYNB(Yeast Nitrogen Base) with Ammonium Sulfate 合成培地にグルコースを2.0%添加した(以下、本明細書中では、YNB-SG培地と称す)。
培地50mlに〔実施例2〕で調製した金銀花及び/又は女貞子抽出液を加え(配合量は表中に記載)、120℃、15分間オートクレーブで滅菌処理を行った。培地を冷却後、1白金耳の酵母菌を植え付け、28℃、150rpm、で4日間培養を行った。培養後、3,000rpm、5分間の遠心分離により、菌体と培養液を分離した。分離した菌体に50%エタノール水溶液3mlを加え、室温で1昼夜放置した。その後3000rpmで5分間遠心分離を行い、上清を取り菌体抽出液とした。
<YNB-SG培地組成>
硫酸アンモニウム5,000、リン酸二水素カリウム1,000、硫酸マグネシウム500、塩化ナトリウム100、塩化カルシウム100、ビオチン0.002、パントテン酸カルシウム0.4、葉酸0.002、イノシトール2.0、ナイアシン0.4、パラアミノ安息香酸0.2、塩酸ピリドキシン0.4、リボフラビン0.2、塩酸チアミン0.4、ホウ酸0.5、硫酸銅0.04、ヨウ化カリウム0.1、塩化第二鉄0.2、硫酸マンガン0.4、モリブデン酸ナトリウム0.2、硫酸亜鉛0.4、グルコース20,000(単位は全てmg/L)。
Yeast culture and medium preparation As a medium, 2.0% glucose was added to YNB (Yeast Nitrogen Base) with Ammonium Sulfate synthetic medium (hereinafter referred to as YNB-SG medium).
The gold and silver flowers and / or Sadako extract prepared in [Example 2] were added to 50 ml of the medium (the blending amount is described in the table), and sterilization was performed in an autoclave at 120 ° C. for 15 minutes. After cooling the medium, 1 platinum ear yeast was planted and cultured at 28 ° C. and 150 rpm for 4 days. After culturing, the cells and the culture solution were separated by centrifugation at 3,000 rpm for 5 minutes. 3 ml of 50% ethanol aqueous solution was added to the separated cells and left at room temperature for 1 day. Thereafter, centrifugation was performed at 3000 rpm for 5 minutes, and the supernatant was taken to obtain a cell extract.
<YNB-SG medium composition>
Ammonium sulfate 5,000, potassium dihydrogen phosphate 1,000, magnesium sulfate 500, sodium chloride 100, calcium chloride 100, biotin 0.002, calcium pantothenate 0.4, folic acid 0.002, inositol 2.0, niacin 0 .4, 0.2 paraaminobenzoic acid, pyridoxine hydrochloride 0.4, riboflavin 0.2, thiamine hydrochloride 0.4, boric acid 0.5, copper sulfate 0.04, potassium iodide 0.1, ferric chloride 0.2, manganese sulfate 0.4, sodium molybdate 0.2, zinc sulfate 0.4, glucose 20,000 (unit is mg / L).
YM培地50mlに〔実施例2〕で調製した金銀花及び/又は女貞子抽出液(配合量は表中に記載:%は抽出液として添加した濃度ある。)を加え、120℃、15分間オートクレーブで滅菌処理を行った。培地を冷却後、1白金耳の酵母菌を植え付け、28℃、150rpm、で4日間培養を行った。培養後、3,000rpm、5分間の遠心分離により、菌体と培養液を分離した。分離した菌体に50%エタノール水溶液3mlを加え、室温で1昼夜放置した。その後3000rpmで5分間遠心分離を行い、上清を取り菌体抽出液とした。 The gold and silver flower and / or Sadako extract prepared in [Example 2] was added to 50 ml of YM medium (the amount is shown in the table:% is the concentration added as the extract), and autoclaved at 120 ° C. for 15 minutes. And sterilized. After cooling the medium, 1 platinum ear yeast was planted and cultured at 28 ° C. and 150 rpm for 4 days. After culturing, the cells and the culture solution were separated by centrifugation at 3,000 rpm for 5 minutes. 3 ml of 50% ethanol aqueous solution was added to the separated cells and left at room temperature for 1 day. Thereafter, centrifugation was performed at 3000 rpm for 5 minutes, and the supernatant was taken to obtain a cell extract.
(処方例3)の化粧水の処方で、金銀花抽出液を添加して培養した酵母菌体抽出液の代わりに〔実施例2〕で示した金銀花抽出液、および女貞子抽出液を用いて作成した化粧水(比較品1、2)、及び天然成分を含有するYM培地に、〔実施例3〕で示した金銀花抽出液、女貞子抽出液を添加して培養した酵母の菌体抽出液を用いた化粧水(比較品3〜5)、合成培地(天然成分を含有しない培地)であるYNB-SG培地に、〔実施例3〕で示した金銀花抽出液、女貞子抽出液を添加して培養した酵母の菌体抽出液を用いた化粧水(試験品1〜3)を作成し、10名の臭い判定専門の官能パネラーを用いて臭いの官能評価を行った。なお、比較品1〜3における金銀花抽出液、女貞子抽出液の化粧水中の濃度、および比較品4〜5、試験品1〜3における酵母菌体抽出液の化粧水中の濃度は蒸発残留物として0.1%になるように調製して化粧水を作成した。 In the formula of the lotion of (Prescription Example 3), the gold and silver flower extract shown in [Example 2] and the Sadako extract are used instead of the yeast cell extract added and cultured with the gold and silver flower extract. The yeast cells cultured by adding the gold and silver flower extract and Sadako extract shown in [Example 3] to the skin lotion (comparative products 1 and 2) prepared in this manner and the YM medium containing natural ingredients. To the lotion (comparative products 3 to 5) using the extract and the YNB-SG medium, which is a synthetic medium (a medium not containing natural ingredients), the gold and silver flower extract and Sadako extract shown in [Example 3] A lotion (test products 1 to 3) was prepared using a yeast cell extract cultivated with the addition of odor, and the sensory evaluation of the odor was performed using 10 panelists specializing in odor determination. In addition, the concentration in the lotion of the gold and silver flower extract and Sadako extract in the comparison products 1 to 3 and the concentration in the lotion of the yeast cell extract in the comparison products 4 to 5 and the test samples 1 to 3 are evaporation residues. As a result, the skin lotion was prepared to 0.1%.
結果を〔表1〕に示した。金銀花、女貞子抽出液を配合した化粧水(比較品1、2)では、臭いが強く、大変気になると答えたパネラーが6名および7名という結果であった。一方、天然物を含むYM培地に金銀花及び/又は女貞子抽出液を添加して培養した酵母菌体抽出液を配合した化粧水(比較品3〜5)では、大変気になるがそれぞれ4名、4名、及び2種混合培養物でも4名となり、いずれも臭いが気になることがわかる。しかし、合成培地であるYNB-SG培地に金銀花、女貞子抽出液を添加して培養した酵母の菌体抽出液を配合した化粧水(試験品1〜3)では、臭いが気にならないと答えたパネラーがそれぞれ6名、5名、および5名となり、金銀花抽出液及び/又は女貞子抽出液含有合成培地で酵母を培養することにより、金銀花抽出液、女貞子抽出液、及び酵母特有の臭いが大幅に低減されたことが分かる。
尚、比較品1〜5、試験品1〜3の色は、化粧品に添加する前の状態で、比較品1、2は、生薬特有の濃い茶色を示し、酵母で培養した比較品3〜5及び試験品1〜3については、透明淡黄色であった。
The results are shown in Table 1. In the lotion (comparative products 1 and 2) containing gold and silver flower and female Sadako extract, the panelists who responded that the smell was strong and they were very worried were 6 and 7. On the other hand, lotions (comparative products 3 to 5) containing a yeast cell extract obtained by adding a gold and silver flower and / or Sadako extract to a YM medium containing a natural product were very anxious. The name, 4 people, and the mixed culture of 2 species are 4 people, and it can be seen that all of them are worried about odor. However, in the skin lotion (test products 1 to 3) containing the yeast cell extract obtained by adding the gold and silver flower and Sadako extract to the synthetic medium YNB-SG medium, the odor does not matter. The responding panelists were 6, 5 and 5, respectively. By culturing yeast in a synthetic medium containing a gold and silver flower extract and / or a female Sadako extract, the gold and silver flower extract, the female Sadako extract, and the yeast It can be seen that the characteristic odor has been greatly reduced.
In addition, the colors of the comparative products 1 to 5 and the test products 1 to 3 are in a state before being added to the cosmetic, and the comparative products 1 and 2 are dark brown peculiar to herbal medicines, and the comparative products 3 to 5 cultured in yeast. And about the test products 1-3, it was transparent light yellow.
以上の結果から、金銀花及び/又は女貞子抽出液における生薬特有の色は、酵母で培養することにより低減するものの、天然物を含む培地で培養した際には、依然臭いを低減することは出来ていないことが分かる。
それに対し、本願発明である、天然物を含まない合成培地に金銀花及び/又は女貞子抽出液を添加する形で培養した場合においては、生薬特有の色も臭いも大幅に低減することが出来、汎用性が広がったと言える。
From the above results, the herbal medicine-specific color in the gold and silver flowers and / or Sadako extract is reduced by culturing in yeast, but when cultured in a medium containing natural products, the odor is still reduced. You can see that it was not done.
On the other hand, when cultivated in the form of adding the gold and silver flower and / or Sadako extract to a synthetic medium that does not contain natural products, which is the present invention, the color and odor peculiar to herbal medicines can be greatly reduced. It can be said that versatility has spread.
DPPH試験
<DPPH溶液の調製>
DPPH溶液は、以下に示す各成分を、(A):(B):(C)=1:4:3容量の割合で混合し調製する。
(A)ES(2-(N-モルホリノ)エタンスルホン酸)5.52gを水100mlに溶かし、1N−NaOHでPH6.1に調製する。
(B)DPPH(1,1−ジフェニルー2−ピクリルヒドラジル)15.7mgをエタノール100mlに溶解する。
(C)精製水
<Trolox溶液の調製>
Trolox25mgをDMSO(ジメチルスルホキシド)10mlに溶解し、10mM溶液を作成した。
<DPPH試験>
測定は試験溶液10μlを96wellplateの1well中に加え、次いでDPPH溶液190μlを迅速に加え混合する。10分後、各wellの吸光度を540nmで測定する。試験溶液のTrolox当量は、0.1mM、0.3mM、0.5mM、1.0mM、3.0mM、5.0mM、10mMのTrolox溶液10μlをとり、DPPH溶液190μlを加え混合し、10分後の540nmの吸光度を測定し、Trolox濃度と540nmの吸光度値の検量線を作成する。試験溶液の540nmの吸光度値から、検量線によりTrolox当量を算出した。標準物質として使用するTroloxは、トコフェロールと類似した構造を有する物質である。Troloxを1とした場合、α-トコフェロール、γ-トコフェロール、δ-トコフェロールは、それぞれ0.50、0.74、1.36を示すといわれているので、Trolox当量が0.5以上であれば、十分な抗酸化効果であると言える。
DPPH test <Preparation of DPPH solution>
The DPPH solution is prepared by mixing the following components in a ratio of (A) :( B) :( C) = 1: 4: 3 volume.
(A) 5.52 g of ES (2- (N-morpholino) ethanesulfonic acid) is dissolved in 100 ml of water and adjusted to pH 6.1 with 1N NaOH.
(B) 15.7 mg of DPPH (1,1-diphenyl-2-picrylhydrazyl) is dissolved in 100 ml of ethanol.
(C) Purified water <Preparation of Trolox solution>
25 mg of Trolox was dissolved in 10 ml of DMSO (dimethyl sulfoxide) to prepare a 10 mM solution.
<DPPH study>
For the measurement, 10 μl of the test solution is added to one well of 96 well plate, and then 190 μl of DPPH solution is rapidly added and mixed. After 10 minutes, the absorbance of each well is measured at 540 nm. The Trolox equivalent of the test solution is 0.1 mM, 0.3 mM, 0.5 mM, 1.0 mM, 3.0 mM, 5.0 mM, 10 mM, 10 μl of Trolox solution, 190 μl of DPPH solution is added and mixed, and 10 minutes later The absorbance at 540 nm is measured, and a calibration curve for the Trolox concentration and the absorbance value at 540 nm is prepared. From the absorbance value of the test solution at 540 nm, Trolox equivalent was calculated using a calibration curve. Trolox used as a standard substance is a substance having a structure similar to that of tocopherol. When Trolox is 1, α-tocopherol, γ-tocopherol, and δ-tocopherol are said to show 0.50, 0.74, and 1.36, respectively, so if Trolox equivalent is 0.5 or more It can be said that this is a sufficient antioxidant effect.
[表2]には、[実施例2]で調製した金銀花抽出液を[実施例3]で示したYNB-SG培地に添加して培養した場合(培養前培地及び培養後の菌体抽出液)のDPPH消去活性をTrolox当量(mM)で示した。尚、各酵母菌体抽出液の濃度は、蒸発残分に換算して約0.35W/V%であった。 金銀花抽出液添加濃度0%において、培養前培地のTrolox当量が0mMであることから、YNB-SG培地そのものには、DPPH消去活性がないことが分かる。つまり、金銀花抽出液が実質的に添加されている培養前培地のTrolox当量は、各添加濃度の金銀花抽出液そのもののTrolox当量を示していると言える。
酵母培養後の菌体抽出液のTrolox当量は、金銀花抽出液の添加濃度に依存して高くなっている。尚、表には示していないが、金銀花抽出液を更に添加した場合においても、濃度依存性が確認された。 培養前培地及び培養後の菌体抽出液のTrolox当量が、近似した数値になっていることから、金銀花抽出液を酵母で培養しても、金銀花抽出液そのものの抗酸化効果は低減していないことが分かる。
尚、金銀花抽出液の各添加濃度において、当初の抽出液に存在した特有の臭い、色は、培養後には大幅に低減されており、金銀花抽出液の当初の抗酸化効果は維持したままで、臭い、色を大幅に低減することが出来ることが確認出来た。
In [Table 2], the gold and silver flower extract prepared in [Example 2] is added to the YNB-SG medium shown in [Example 3] and cultured (pre-culture medium and bacterial cell extraction after culture). The DPPH scavenging activity of the liquid was shown as Trolox equivalent (mM). The concentration of each yeast cell extract was about 0.35 W / V% in terms of evaporation residue. Since the Trolox equivalent of the pre-culture medium is 0 mM at a gold / silver flower extract addition concentration of 0%, it can be seen that the YNB-SG medium itself has no DPPH elimination activity. That is, it can be said that the Trolox equivalent of the pre-culture medium to which the gold and silver flower extract is substantially added indicates the Trolox equivalent of the gold and silver flower extract itself at each added concentration.
The Trolox equivalent of the cell extract after culturing yeast is high depending on the concentration of the gold and silver flower extract added. Although not shown in the table, concentration dependency was confirmed even when the gold and silver flower extract was further added. Since the Trolox equivalents of the culture medium before culture and the cell extract after culture are close to each other, even if the gold and silver flower extract is cultured in yeast, the antioxidant effect of the gold and silver flower extract itself is reduced. I understand that it is not.
In addition, at each added concentration of the gold and silver flower extract, the characteristic odor and color present in the original extract are greatly reduced after the culture, and the original antioxidant effect of the gold and silver flower extract is maintained. It was confirmed that the odor and color could be greatly reduced.
[表3]には、[実施例2]で調製した女貞子抽出液を[実施例3]で示したYNB-SG培地に添加して培養した場合(培養前培地及び培養後の菌体抽出液)のDPPH消去活性をTrolox当量(mM)で示した。尚、各酵母菌体抽出液の濃度は、蒸発残分に換算して約0.35W/V%であった。 女貞子抽出液添加濃度0%において、培養前培地のTrolox当量が0mMであることから、YNB-SG培地そのものには、DPPH消去活性がないことが分かる。つまり、女貞子抽出液が実質的に添加されている培養前培地のTrolox当量は、各添加濃度の女貞子抽出液そのもののTrolox当量を示していると言える。
酵母培養後の菌体抽出液のTrolox当量は、女貞子抽出液の添加濃度に依存して高くなっている。尚、表には示していないが、女貞子抽出液を更に添加した場合においても、濃度依存性が確認された。 培養前培地及び培養後の菌体抽出液のTrolox当量が、近似した数値になっていることから、女貞子抽出液を酵母で培養しても、女貞子抽出液そのものの抗酸化効果は低減していないことが分かる。
尚、女貞子抽出液の各添加濃度において、当初の抽出液に存在した特有の臭い、色は、培養後には大幅に低減されており、女貞子抽出液の当初の抗酸化効果は維持したままで、臭い、色を大幅に低減することが出来ることが確認出来た。
In [Table 3], when the Sadako extract prepared in [Example 2] is added to the YNB-SG medium shown in [Example 3] and cultured (the medium before and after the cultivation) The DPPH scavenging activity of the liquid was shown as Trolox equivalent (mM). The concentration of each yeast cell extract was about 0.35 W / V% in terms of evaporation residue. Since the Trolox equivalent of the pre-culture medium is 0 mM at 0% Sadako extract concentration, it can be seen that the YNB-SG medium itself does not have DPPH elimination activity. That is, it can be said that the Trolox equivalent of the pre-culture medium to which the Sadako extract is substantially added indicates the Trolox equivalent of the Sadako extract itself at each added concentration.
The Trolox equivalent of the cell extract after yeast culture is high depending on the concentration of the Sadako extract. Although not shown in the table, concentration dependency was confirmed even when the Sadako extract was further added. Since the Trolox equivalents of the culture medium before culture and the cell extract after culture are close to each other, even if the Sadako extract is cultured in yeast, the antioxidant effect of the Sadako extract itself is reduced. I understand that it is not.
In addition, at each added concentration of Sadako extract, the characteristic odor and color that existed in the original extract were greatly reduced after cultivation, and the original antioxidant effect of Sadako extract was maintained. It was confirmed that the odor and color could be greatly reduced.
[表4]には、[実施例2]で調製した金銀花抽出液及び女貞子抽出液を[実施例3]で示したYNB-SG培地に添加して培養した場合(培養前培地及び培養後の菌体抽出液)のDPPH消去活性をTrolox当量(mM)で示した。尚、各酵母菌体抽出液の濃度は、蒸発残分に換算して約0.35W/V%であった。
金銀花抽出液及び女貞子抽出液を併用した場合においても、各抽出液を単独で添加した場合同様の傾向が見られた。つまり、金銀花抽出液及び女貞子抽出液を酵母で培養しても、金銀花抽出液及び女貞子抽出液そのものの抗酸化効果は低減せず、金銀花抽出液及び女貞子抽出液の各添加濃度において、当初の抽出液に存在した特有の臭い、色は、培養後には大幅に低減されており、金銀花抽出液及び女貞子抽出液の当初の抗酸化効果は維持したままで、臭い、色を大幅に低減することが出来ることが確認出来た。
In [Table 4], the gold and silver flower extract and Sadako extract prepared in [Example 2] were added to the YNB-SG medium shown in [Example 3] and cultured (pre-culture medium and culture). The DPPH scavenging activity of the subsequent bacterial cell extract) was shown as Trolox equivalent (mM). The concentration of each yeast cell extract was about 0.35 W / V% in terms of evaporation residue.
Even when the gold and silver flower extract and Sadako extract were used in combination, the same tendency was observed when each extract was added alone. In other words, culturing the gold and silver flower extract and Sadako extract in yeast does not reduce the antioxidant effect of the gold and silver flower extract and Sadako extract itself. In terms of concentration, the characteristic odor and color that were present in the original extract were greatly reduced after the culture, while maintaining the original antioxidant effect of the gold and silver flower extract and Sadako extract, while maintaining the odor, It was confirmed that the color could be greatly reduced.
次に、[表5]に示した酵母菌の生育に必要な最小限の栄養源からなる合成培地(詳細は表に記載;各成分の単位はg/100ml)を100mlの三角フラスコに50ml作成し、本願発明の金銀花抽出液を培地に5%添加して(表中は蒸発残分に換算した濃度W/V%)滅菌した後、酵母菌を植菌し1週間、24℃にて150rpmで回転培養を行い、菌体の生育度、Trolox当量、臭いを確認した。比較例としてYNB-SG培地で培養したものについても同様の項目を確認した。
菌体抽出液は得られた菌体に、50%エタノール水溶液を3ml添加し、5℃、24時間放置撹拌後、5,000rpmにて遠心分離した上清を菌体抽出液とした。
<菌体の生育度>
培養して得られた、培養液を3,000rpmで10分間遠心分離を行い、培養上清を除去し、増殖した酵母菌体を回収し、回収した菌体湿重量を測定した。
<Trolox当量>
前述の[実施例5]と同様の方法で行った。
<臭いの確認>
各培地において培養後に、上記方法で得られた菌体抽出液を作成して臭いを確認した。
(判定基準)
◎:臭いなし。
○:やや臭いはあるが、気にならない。
×:臭いあり。
<色の確認>
各培地において培養後に、得られた前記菌体抽出液の色を下記の判定基準に従って評価した。
(判定基準)
◎:色なし。
○:やや色はあるが、気にならない。
×:色あり。
Next, 50 ml of a synthetic medium (details are given in the table; the unit of each component is g / 100 ml) composed of the minimum nutrients necessary for the growth of yeast shown in [Table 5] is prepared in 50 ml. Then, after adding 5% of the gold and silver flower extract of the present invention to the medium (concentration W / V% converted to evaporation residue in the table) and sterilizing, inoculate the yeast and incubate at 24 ° C for 1 week. Rotational culture was performed at 150 rpm, and the growth degree, Trolox equivalent and odor of the cells were confirmed. As a comparative example, the same items were confirmed for those cultured in YNB-SG medium.
As a bacterial cell extract, 3 ml of 50% ethanol aqueous solution was added to the obtained bacterial cells, left to stir at 5 ° C. for 24 hours, and then centrifuged at 5,000 rpm to obtain a bacterial cell extract.
<Growth of cells>
The culture solution obtained by culturing was centrifuged at 3,000 rpm for 10 minutes, the culture supernatant was removed, the grown yeast cells were collected, and the collected wet cell weight was measured.
<Trolox equivalent>
The same method as in [Example 5] was performed.
<Odor confirmation>
After culturing in each medium, the microbial cell extract obtained by the above method was prepared to confirm the odor.
(Criteria)
A: No smell.
○: There is a slight smell, but I do not mind.
X: There is a smell.
<Check color>
After culturing in each medium, the color of the obtained bacterial cell extract was evaluated according to the following criteria.
(Criteria)
A: No color.
○: There is a slight color, but I do not care.
X: There is color.
[表5]中、上段は金銀花抽出液を添加した培地におけるTrolox量、臭い、色について評価した。下段は、金銀花抽出液を添加していない培地のTrolox量を参考に示した。下段は金銀花抽出液を培地中に添加していないので、臭いはなく、色も無色であった。
表5の結果より、(A)炭素源、(B)窒素源、(C)リン源からなる合成培地に金銀花抽出液を添加した培地で培養した場合であっても、高い抗酸化効果を維持し、臭いも色も気にならない抗酸化剤が得ることが出来た。
尚、(A)炭素源を含まない場合は、極端に菌が生育しなかった為、表に示さず。
In [Table 5], the upper part evaluated the amount of Trolox, smell, and color in the culture medium to which the gold and silver flower extract was added. The lower row shows the Trolox amount of the medium not added with the gold and silver flower extract for reference. In the lower row, no gold and silver flower extract was added to the medium, so there was no odor and the color was colorless.
From the result of Table 5, even when it is a case where it culture | cultivates with the culture medium which added the gold-silver flower extract to the synthetic culture medium which consists of (A) carbon source, (B) nitrogen source, and (C) phosphorus source, it has a high antioxidant effect. It was possible to obtain an antioxidant that was maintained and did not bother with odor or color.
In addition, when (A) a carbon source is not included, since a microbe did not grow extremely, it does not show in a table | surface.
次に、本発明の培養処理液を配合した処方例を示すが、本発明はこれに限定されるものでない。 Next, although the formulation example which mix | blended the culture processing liquid of this invention is shown, this invention is not limited to this.
化粧料の処方例
以下の化粧料の処方例で示す酵母菌体抽出液は、YNB-SG培地で、金銀花及び/又は女貞子抽出液を0.2%添加して培養した酵母菌体抽出液を示す。尚、下記に示した酵母菌体抽出液の配合量は、抽出液としての量である。カッコ内に蒸発残分としての量を併記した。
(処方例1)化粧用クリーム(質量%)
a)ミツロウ・・・2.0
b)ステアリルアルコール・・・5.0
c)ステアリン酸・・・8.0
d)スクワラン・・・10.0
e)自己乳化型グリセリルモノステアレート・・・3.0
f)ポリオキシエチレンセチルエーテル(20E.O.)・・・1.0
g)金銀花抽出液を添加して培養した酵母菌体抽出液・・・10.0(0.035)
h)1,3−ブチレングリコール・・・5.0
i)水酸化カリウム・・・0.3
j)防腐剤・酸化防止剤・・・適量
k)精製水・・・残部
製法
a)〜f)までを加熱溶解し、80℃に保つ。h)〜k)までを加熱溶解し、80℃に保ち、a)〜f)に加えて乳化し、40℃まで撹拌しながら冷却する。その後、g)を加え、攪拌し均一に溶解する。
Example of cosmetic formulation The yeast cell extract shown in the following cosmetic formulation example is YNB-SG medium, and 0.2% of gold and silver flower and / or Sadako extract is added and cultured. Indicates liquid. In addition, the compounding quantity of the yeast cell extract shown below is the quantity as an extract. The amount as evaporation residue is also shown in parentheses.
(Formulation Example 1) Cosmetic cream (mass%)
a) Beeswax 2.0
b) Stearyl alcohol ... 5.0
c) Stearic acid ... 8.0
d) Squalane ... 10.0
e) Self-emulsifying glyceryl monostearate 3.0
f) Polyoxyethylene cetyl ether (20E.O.) ... 1.0
g) Extract of yeast cells cultured by adding gold and silver flower extract ... 10.0 (0.035)
h) 1,3-butylene glycol ... 5.0
i) Potassium hydroxide ... 0.3
j) Preservative / Antioxidant: appropriate amount k) Purified water: Remaining preparation methods a) to f) are heated and dissolved and kept at 80 ° C. Heat up to h) to k), keep at 80 ° C., add to a) to f), emulsify, and cool to 40 ° C. with stirring. Then g) is added and stirred to dissolve uniformly.
(処方例2)乳液(質量%)
a)ミツロウ・・・0.5
b)ワセリン・・・2.0
c)スクワラン・・・8.0
d)ソルビタンセスキオレエート・・・0.8
e)ポリオキシエチレンオレイルエーテル(20E.O.)・・・1.2
f)女貞子抽出液を添加して培養した酵母菌体抽出液・・・0.1(0.00035)
g)1,3−ブチレングリコール・・・7.0
h)カルボキシビニルポリマー・・・0.2
i)水酸化カリウム・・・0.1
j)精製水・・・残部
k)防腐剤・酸化防止剤・・・適量
l)エタノール・・・7.0
製法
a)〜e)までを加熱溶解し、80℃に保つ。g)〜k)までを加熱溶解し、80℃に保ち、a)〜e)に加えて乳化し、50℃まで撹拌しながら冷却する。50℃でf)、l)を添加し、40℃まで攪拌、冷却する。
(Prescription Example 2) Emulsion (mass%)
a) Beeswax 0.5
b) Petrolatum 2.0
c) Squalane ... 8.0
d) Sorbitan sesquioleate ... 0.8
e) Polyoxyethylene oleyl ether (20EO) 1.2
f) Yeast extract extracted with Sadako extract and cultured 0.1 ... (0.00035)
g) 1,3-butylene glycol 7.0
h) Carboxyvinyl polymer 0.2
i) Potassium hydroxide ... 0.1
j) Purified water: balance k) antiseptic / antioxidant ... appropriate amount l) ethanol ... 7.0
The production methods a) to e) are dissolved by heating and kept at 80 ° C. G) to k) are heated and dissolved, kept at 80 ° C., added to a) to e), emulsified, and cooled to 50 ° C. with stirring. Add f), l) at 50 ° C., stir to 40 ° C. and cool.
(処方例3)化粧水(質量%)
a)金銀花抽出液を添加して培養した酵母菌体抽出液・・・5.0(0.0175)
b)グリセリン・・・5.0
c)ポリオキシエチレンソルビタンモノラウレート(20E.O.)・・・1.0
d)エタノール・・・6.0
e)香料・・・適量
f)防腐剤・酸化防止剤・・・適量
g)精製水・・・残部
製法
a)〜g)までを混合し、均一に溶解する。
(Formulation Example 3) Lotion (mass%)
a) Extract of yeast cells cultured by adding gold and silver flower extract ... 5.0 (0.0175)
b) Glycerin ... 5.0
c) Polyoxyethylene sorbitan monolaurate (20EO) ... 1.0
d) Ethanol ... 6.0
e) Perfume ... appropriate amount f) antiseptic / antioxidant ... appropriate amount g) purified water ... the remaining preparation methods a) to g) are mixed and dissolved uniformly.
(処方例4)洗顔料(質量%)
a)ステアリン酸・・・12.0
b)ミリスチン酸・・・14.0
c)ラウリン酸・・・5.0
d)ホホバ油・・・3.0
e)グリセリン・・・10.0
f)ソルビトール・・・15.0
g)1,3−ブチレングリコール・・・10.0
h)POE(20)グリセロールモノステアリン酸・・・2.0
i)水酸化カリウム・・・5.0
j)水・・・残部
k)キレート剤・・・適量
l)香料・・・適量
m)金銀花抽出液を添加して培養した酵母菌体抽出液・・・1.0(0.0035)
n)女貞子抽出液を添加して培養した酵母菌体抽出液・・・1.0(0.0035)
製法
a)〜h)までを加熱溶解し70℃に保つ。j)にi)を溶解後a)〜h)に加えケン化する。その後k)、l)を入れ攪拌しながら冷却する。50℃でm)、n)を添加し、40℃まで攪拌、冷却する。
(Formulation example 4) Face wash (mass%)
a) Stearic acid ... 12.0
b) Myristic acid 14.0
c) Lauric acid ... 5.0
d) Jojoba oil ... 3.0
e) Glycerin 10.0
f) Sorbitol ... 15.0
g) 1,3-butylene glycol ... 10.0
h) POE (20) Glycerol monostearic acid 2.0
i) Potassium hydroxide ... 5.0
j) Water ... balance k) chelating agent ... appropriate amount l) perfume ... appropriate amount m) yeast cell extract added with gold and silver flower extract and cultured 1.0 (0.0035)
n) Yeast cell extract cultivated with Sadako extract added ... 1.0 (0.0035)
The manufacturing methods a) to h) are dissolved by heating and maintained at 70 ° C. After i) is dissolved in j), it is added to a) to h) and saponified. Then, k) and l) are added and cooled with stirring. Add m), n) at 50 ° C., stir to 40 ° C. and cool.
(処方例5)化粧水(質量%)
a)金銀花抽出液を添加して培養した酵母菌体抽出液・・・10.0(0.035)
b)女貞子抽出液を添加して培養した酵母菌体抽出液・・・5.0(0.0175)
c)グリセリン・・・5.0
d)ポリオキシエチレンソルビタンモノラウレート(20E.O.)・・・1.0
e)エタノール・・・6.0
f)香料・・・適量
g)防腐剤・酸化防止剤・・・適量
h)精製水・・・残部
製法
a)〜h)までを混合し、均一に溶解する。
(Formulation Example 5) Lotion (mass%)
a) Extract of yeast cells cultured by adding gold and silver flower extract 10.0 (0.035)
b) Yeast cell extract extracted with female Sadako extract added and cultured 5.0 (0.0175)
c) Glycerin ... 5.0
d) Polyoxyethylene sorbitan monolaurate (20EO) ... 1.0
e) Ethanol ... 6.0
f) Perfume ... appropriate amount g) antiseptic / antioxidant ... appropriate amount h) purified water ... the remaining preparation methods a) to h) are mixed and dissolved uniformly.
(処方例6)化粧水(質量%)
a)金銀花抽出液と女貞子抽出液を添加して培養した酵母菌体抽出液・・・5.0(0.0175)
b)グリセリン・・・5.0
c)ポリオキシエチレンソルビタンモノラウレート(20E.O.)・・・1.0
d)エタノール・・・6.0
e)香料・・・適量
f)防腐剤・酸化防止剤・・・適量
g)精製水・・・残部
製法
a)〜g)までを混合し、均一に溶解する。
(Formulation Example 6) Lotion (mass%)
a) Extract of yeast cells cultured by adding the gold and silver flower extract and Sadako extract ... 5.0 (0.0175)
b) Glycerin ... 5.0
c) Polyoxyethylene sorbitan monolaurate (20EO) ... 1.0
d) Ethanol ... 6.0
e) Perfume ... appropriate amount f) antiseptic / antioxidant ... appropriate amount g) purified water ... the remaining preparation methods a) to g) are mixed and dissolved uniformly.
以上詳述したごとく、本発明によれば、色及び臭いが大幅に低減された、高い抗酸化剤を得る事が可能になる。本抗酸化剤を添加した抗酸化化粧料は、紫外線や、外的環境から受ける肌の炎症などにより生じる光老化によるシワの改善に幅広く適用することができる。
As described in detail above, according to the present invention, it is possible to obtain a high antioxidant with greatly reduced color and odor. Antioxidant cosmetics to which the present antioxidant is added can be widely applied to the improvement of wrinkles caused by photoaging caused by ultraviolet rays and skin inflammation from the external environment.
Claims (5)
(A)炭素源として、単糖類、二糖類、三糖類から選択される1種以上
(B)窒素源として、硝酸塩、アンモニウム塩、尿素、アミノ酸から選択される1種以上
(C)リン源として、リン酸塩から選択される1種以上 The antioxidant according to claim 1, which is a synthetic medium comprising the following (A), (B) and (C).
(A) One or more types selected from monosaccharides, disaccharides and trisaccharides as a carbon source (B) One or more types selected from nitrates, ammonium salts, urea and amino acids as a nitrogen source (C) As a phosphorus source One or more selected from phosphates
(A)炭素源として、リボース、アラビノース、キシロース、グルコース、フルクトース、マンノース、ガラクトース、ラムノース、シュクロース、マルトース、ラクトース、トレハロース、セロビオース、ラフィノース、マルトトリオースから選択される1種以上
(B)窒素源として、硝酸カリウム、硝酸ナトリウム、硝酸カルシウム、硫酸アンモニウム、塩化アンモニウム、トリプトファン、リシン、メチオニン、フェニルアラニン、トレオニン、バリン、イソロイシン、ロイシン、ヒスチジン、アラニン、アルギニン、アスパラギン、セリン、アスパラギン酸、システイン、グルタミン、グルタミン酸、グリシン、プロリン、チロシンから選択される1種以上
(C)リン源として、リン酸1水素カリウム、リン酸2水素カリウム、リン酸アンモニウムから選択される1種以上 The antioxidant according to any one of claims 1 to 2, which is a synthetic medium comprising the following (A), (B), and (C).
(A) One or more types selected from ribose, arabinose, xylose, glucose, fructose, mannose, galactose, rhamnose, sucrose, maltose, lactose, trehalose, cellobiose, raffinose, maltotriose as a carbon source (B) nitrogen Sources include potassium nitrate, sodium nitrate, calcium nitrate, ammonium sulfate, ammonium chloride, tryptophan, lysine, methionine, phenylalanine, threonine, valine, isoleucine, leucine, histidine, alanine, arginine, asparagine, serine, aspartic acid, cysteine, glutamine, glutamic acid As one or more (C) phosphorus sources selected from glycine, proline and tyrosine, potassium monohydrogen phosphate, potassium dihydrogen phosphate, phosphoric acid One or more selected from Moniumu
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011079710A JP5758174B2 (en) | 2011-03-31 | 2011-03-31 | Antioxidants and antioxidant cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011079710A JP5758174B2 (en) | 2011-03-31 | 2011-03-31 | Antioxidants and antioxidant cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012214392A JP2012214392A (en) | 2012-11-08 |
JP5758174B2 true JP5758174B2 (en) | 2015-08-05 |
Family
ID=47267602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011079710A Active JP5758174B2 (en) | 2011-03-31 | 2011-03-31 | Antioxidants and antioxidant cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5758174B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020004858A1 (en) * | 2018-06-25 | 2020-01-02 | (주)코엔바이오 | Diabetes-alleviating or antioxidant composition comprising yeast extract and method for preparing yeast extract |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6312985B2 (en) * | 2013-03-25 | 2018-04-18 | 梁瀬 美智代 | Liquid composition |
JP6433678B2 (en) * | 2014-05-01 | 2018-12-05 | 日本メナード化粧品株式会社 | External preparations and internal preparations containing the extract |
CN107167613B (en) * | 2017-06-22 | 2018-10-02 | 深圳清华大学研究院 | Albumen spotting buffer for plasma gold chip |
WO2019167177A1 (en) * | 2018-02-28 | 2019-09-06 | ワミレスコスメティックス株式会社 | Topical skin composition containing marine-derived yeast culture |
TWI784229B (en) * | 2019-05-21 | 2022-11-21 | 大江生醫股份有限公司 | Lonicera japonica thunb ferment, preparation method thereof and use thereof for improving skin appearance and anti-aging |
KR102284112B1 (en) * | 2019-10-07 | 2021-08-03 | (주)코엔바이오 | A composition for lowering blood glucose level or blood pressure or for use of antioxidant comprising Rhynchosia nulubilis fermented by a yeast and a method for preparing the composition |
CN112656838B (en) * | 2020-12-31 | 2022-04-15 | 广东丸美生物技术股份有限公司 | Pharmaceutical composition, preparation method and application thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2618286B2 (en) * | 1990-10-25 | 1997-06-11 | 免疫代謝薬製造株式会社 | Hypotensive yeast preparation and its production method |
FR2673841B1 (en) * | 1991-03-12 | 1995-03-10 | Sanofi Elf | COSMETIC COMPOSITION BASED ON TRANSFER PROTEIN. |
JP3990067B2 (en) * | 1999-04-05 | 2007-10-10 | 長谷川香料株式会社 | Purification method of natural pigment |
JP2002020300A (en) * | 2000-07-07 | 2002-01-23 | Ichimaru Pharcos Co Ltd | Cosmetic composition |
CN102670453A (en) * | 2001-10-09 | 2012-09-19 | 株式会社芳凯尔 | Compositions for potentiating glutatthione |
AU2003239327B8 (en) * | 2002-05-02 | 2008-06-19 | E-L Management Corp. | Method of enhancing biological activity of plant extracts |
JP3668722B2 (en) * | 2002-06-14 | 2005-07-06 | 株式会社ラティアクリエイツ | Antioxidant composition |
JP2004173692A (en) * | 2002-11-14 | 2004-06-24 | Oubiken:Kk | Method for producing fermented sesame |
JP2004262853A (en) * | 2003-03-03 | 2004-09-24 | Kanebo Ltd | Cosmetic |
JP2004345986A (en) * | 2003-05-21 | 2004-12-09 | Ryukyu Bio Resource Kaihatsu:Kk | Fermented material and method for producing the same |
JP2005104962A (en) * | 2003-09-12 | 2005-04-21 | Kose Corp | Dermal external agent |
-
2011
- 2011-03-31 JP JP2011079710A patent/JP5758174B2/en active Active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020004858A1 (en) * | 2018-06-25 | 2020-01-02 | (주)코엔바이오 | Diabetes-alleviating or antioxidant composition comprising yeast extract and method for preparing yeast extract |
KR20200000743A (en) * | 2018-06-25 | 2020-01-03 | (주)코엔바이오 | A composition for improving diabetes or for use of antioxidant comprising yeast extract and a method for preparing the yeast extract |
KR102123030B1 (en) * | 2018-06-25 | 2020-06-16 | (주)코엔바이오 | A composition for improving diabetes or for use of antioxidant comprising yeast extract and a method for preparing the yeast extract |
Also Published As
Publication number | Publication date |
---|---|
JP2012214392A (en) | 2012-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6185041B2 (en) | Glycerol production promoter derived from Staphylococcus epidermidis, antibacterial peptide production promoter derived from skin epidermis keratinocytes, and their use as an external preparation for skin protection | |
JP5758174B2 (en) | Antioxidants and antioxidant cosmetics | |
JP5663187B2 (en) | Antioxidants, UV damage inhibitors and anti-aging cosmetics | |
KR20110096102A (en) | Antimicrobial composition with extracts of natural materials, naturotics and manufacturing method thereof | |
JP6321402B2 (en) | Cell differentiation promoting agent and cosmetics | |
JP5612888B2 (en) | Antioxidants, UV damage inhibitors and anti-aging cosmetics | |
KR20110086894A (en) | Cosmetic included to alkaline powder & solution of shell | |
JP2006008566A (en) | Cosmetic agent containing lactic acid bacteria fermentation product of fruit juice as active ingredient and its application | |
JP2015157773A (en) | cosmetic | |
KR20170052811A (en) | yeast fermented solutions of green tea extract and manufacturing method thereof and cosmetic composition using the same | |
JP2000178168A (en) | Elastase activity inhibitor and cosmetic composition | |
JP5758175B2 (en) | Antioxidants and antioxidant cosmetics | |
JP2007145790A (en) | Cosmetic | |
JP2006347925A (en) | Plant fermentation product and cosmetic containing the same | |
JP5054945B2 (en) | Cosmetics | |
JP4033808B2 (en) | Beauty / health material containing Himefuuro extract | |
JP2015157770A (en) | cosmetic | |
JP2005089355A (en) | Isomaltooligosaccharide-containing ameliorant for indigenous skin bacterial flora | |
JP2006124356A (en) | INTERLEUKIN-1alpha PRODUCTION INHIBITOR | |
JP2002363088A (en) | Elastase activity inhibitor or cosmetic composition | |
JP5635292B2 (en) | Antioxidants and UV damage inhibitors | |
JP2004238310A (en) | Cosmetic composition, drink or food | |
JP2002284663A (en) | Cosmetic composition | |
JP2005035957A (en) | External preparation composition for iontophoresis containing polyglutamic acid or its salt | |
JP2002363057A (en) | Melanogenesis inhibitor or cosmetic composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140228 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140812 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20141007 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141120 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150602 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150603 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5758174 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |